MrTurtle的个人主页 - 老虎社区

MrTurtle

MrTurtle

暂无个人介绍

IP属地：未知

30关注

5粉丝

0主题

0勋章

2021-12-17

Soon Apple will not be reliant on Intel and Qualcomm anymore

抱歉，原内容已删除

2021-12-14

Like pls

抱歉，原内容已删除

2021-12-24

Christmas hype

抱歉，原内容已删除

2021-12-16

Amazing how the market turned green with the news and expectations of this

Dow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote>

2021-12-15

Like

抱歉，原内容已删除

2021-12-11

Continue to drop pls haha

Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>

2021-12-09

Booster again..

Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞称加强剂中和了奥密克戎病毒，但变种可能无法注射两剂</blockquote>

2021-12-21

No way home

Disney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote>

2021-12-19

Let's go up up up

Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>

2021-12-12

Fella is eccentric

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582014945835134","uuid":"3582014945835134","gmtCreate":1618922861023,"gmtModify":1639013434571,"name":"MrTurtle","pinyin":"mrturtle","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":30,"tweetSize":23,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":696534216,"gmtCreate":1640733161632,"gmtModify":1640733161728,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696534216","repostId":"1186633322","repostType":4,"isVote":1,"tweetType":1,"viewCount":3026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696146728,"gmtCreate":1640654974162,"gmtModify":1640654974262,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Merry christmas and happy new year boomz","listText":"Merry christmas and happy new year boomz","text":"Merry christmas and happy new year boomz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696146728","repostId":"2194361107","repostType":4,"isVote":1,"tweetType":1,"viewCount":3057,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698752727,"gmtCreate":1640564025134,"gmtModify":1640564025361,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698752727","repostId":"1152446317","repostType":4,"repost":{"id":"1152446317","kind":"news","pubTimestamp":1640562302,"share":"https://www.laohu8.com/m/news/1152446317?lang=zh_CN&edition=full","pubTime":"2021-12-27 07:45","market":"us","language":"en","title":"Wall Street Bets S&P 500 Will Say Goodbye to Outsize Stock Gains in 2022<blockquote>华尔街押注标普500将在2022年告别股价大幅上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152446317","media":"WSJ","summary":"U.S. stocks are on track to end 2021 with another year of outsize gains. Many investors aren’t expec","content":"<p>U.S. stocks are on track to end 2021 with another year of outsize gains. Many investors aren’t expecting a repeat in 2022.</p><p><blockquote>美国股市有望在2021年结束时迎来又一年的大幅上涨。许多投资者预计2022年不会重演。</blockquote></p><p> The S&amp;P 500 has climbed 26% so far in 2021, after rising 16% in 2020. Rip-roaring corporate profits and easy monetary policy have fueled the run. Earnings growth is expected to moderate next year, and the Federal Reserve is pursuing&nbsp;plans to raise interest rates, chipping away at key supports for the stock market’s rally.</p><p><blockquote>标普500在2020年上涨16%后，2021年迄今已上涨26%。飙升的企业利润和宽松的货币政策推动了这一挤兑。预计明年盈利增长将放缓，美联储正在推行加息计划，削弱了股市上涨的关键支撑。</blockquote></p><p> When rates are low, investors tend to load up on risk assets such as stocks to generate returns. When inflation accelerates and policy makers raise interest rates, the value of companies’ future earnings drops and investors have more alternatives for places to make money.</p><p><blockquote>当利率较低时，投资者往往会买入股票等风险资产以产生回报。当通胀加速、政策制定者加息时，公司未来盈利的价值就会下降，投资者就有更多赚钱的选择。</blockquote></p><p> Rock-bottom interest rates early in 2020 helped propel equity valuations higher, and they have remained elevated in the months since. Many analysts and investors now believe that increasing rates are likely to keep valuations from rising further, and might cause them to fall.</p><p><blockquote>2020年初的最低利率帮助推高了股票估值，并且在此后的几个月里一直保持在高位。许多分析师和投资者现在认为，加息可能会阻止估值进一步上升，并可能导致估值下跌。</blockquote></p><p> Though stock indexes often continue to rise early in a cycle of interest-rate increases, tighter monetary policy puts portfolio managers on a shorter leash and makes many of them guarded about taking on more risk.</p><p><blockquote>尽管股指往往在加息周期的早期继续上涨，但收紧的货币政策使投资组合经理受到更短的约束，并使他们中的许多人对承担更多风险持谨慎态度。</blockquote></p><p> “We know there’s going to be a rate hike,” said Tiffany Wade, senior portfolio manager at Columbia Threadneedle Investments. “How soon before that do you start to position around valuations maybe coming off?”</p><p><blockquote>Columbia Threadneedle Investments高级投资组合经理蒂芙尼·韦德(Tiffany Wade)表示：“我们知道将会加息。”“在此之前，你多久会开始围绕估值可能会下降进行定位？”</blockquote></p><p> The S&amp;P 500 traded last week at about 21 times its projected earnings over the next 12 months, above a five-year average of a little less than 19 times, according to FactSet.</p><p><blockquote>FactSet的数据显示，这家标普500上周的市盈率约为未来12个月预期市盈率的21倍，高于略低于19倍的五年平均水平。</blockquote></p><p> Some strategists think the shift in monetary policy could help limit stock gains to levels more in keeping with their long-term trend. The S&amp;P 500 has averaged an annual gain of 8.4% from 1957, the year it was introduced, through last year. But it is coming off three much stronger years. The index jumped 29% in 2019, even more than its advances in 2020 and so far in 2021.</p><p><blockquote>一些策略师认为，货币政策的转变可能有助于将股市涨幅限制在更符合长期趋势的水平。从1957年推出到去年，标普500的平均年增长率为8.4%。但这三年表现强劲得多。该指数在2019年上涨了29%，甚至超过了2020年和2021年迄今为止的涨幅。</blockquote></p><p> “That’s not normal,” said Joseph Amato, president and chief investment officer of equities at asset manager Neuberger Berman. “That’s been an extraordinary period of return, and our expectation is you’re not going to see that kind of market performance in ’22.”</p><p><blockquote>“这不正常，”资产管理公司路博迈(Neuberger Berman)总裁兼首席股票投资官约瑟夫·阿马托(Joseph Amato)表示。“这是一个非凡的回报时期，我们的预期是，22年你不会看到这样的市场表现。”</blockquote></p><p> There is reason, of course, to be humble about stock predictions: Analysts can’t forecast world events, or even how the market will react to them. Many analysts thought stocks would plunge throughout 2020 after the Covid-19 pandemic hit the U.S. A year ago, analysts underestimated the strength of the market’s 2021 rally.</p><p><blockquote>当然，我们有理由对股票预测保持谦虚：分析师无法预测世界事件，甚至无法预测市场对这些事件的反应。许多分析师认为，在Covid-19大流行袭击美国后，股市将在2020年全年暴跌。一年前，分析师低估了市场2021年反弹的力度。</blockquote></p><p> “One year is such a short period that it’s really hard to accurately forecast where stocks will be in a year from now,” said Aneet Chachra, portfolio manager at Janus Henderson Investors.</p><p><blockquote>Janus Henderson Investors投资组合经理Aneet Chachra表示：“一年的时间很短，很难准确预测一年后股市的走势。”</blockquote></p><p> Still, many of the structures that have supported the market will fade next year. Gains in 2020 and 2021 have been propped up by government spending and central-bank interventions, including the near-zero interest rates.</p><p><blockquote>尽管如此，许多支撑市场的结构将在明年消失。2020年和2021年的收益受到政府支出和央行干预（包括接近零的利率）的支撑。</blockquote></p><p> This month the Fed laid the groundwork for&nbsp;interest-rate increases&nbsp;starting as early as next spring and approved plans to wind down a bond-buying stimulus program more quickly. Democrats’ roughly $2 trillion&nbsp;education, healthcare and climate package&nbsp;faces an uncertain future after Sen. Joe Manchin (D., W.Va.) said last week he would oppose it.</p><p><blockquote>本月，美联储为最早于明年春天开始的加息奠定了基础，并批准了更快结束债券购买刺激计划的计划。民主党大约2万亿美元的教育、医疗和气候一揽子计划面临着不确定的未来，此前西弗吉尼亚州民主党参议员乔·曼钦（Joe Manchin）上周表示他将反对该计划。</blockquote></p><p> Wall Street strategists are forecasting smaller gains for the S&amp;P 500 in 2022. Among 13 banks and financial services firms whose analysts have published 2022 forecasts, the average target for the S&amp;P 500 to end next year is 4940, about 4.5% above where the index closed Thursday.</p><p><blockquote>华尔街策略师预测，2022年标普500的涨幅将较小。在分析师已发布2022年预测的13家银行和金融服务公司中，明年结束的标普500的平均目标为4940点，比该指数周四收盘价高出约4.5%。</blockquote></p><p> On the high end of next year’s projections, strategists at BMO Capital Markets are forecasting the S&amp;P 500 will finish 2022 at 5300, 12% above its current level. The BMO team expects company earnings growth will help push stocks higher.</p><p><blockquote>BMO Capital Markets的策略师预测，2022年标普500将达到5300点，比当前水平高出12%。BMO团队预计公司盈利增长将有助于推高股价。</blockquote></p><p> Strategists at Morgan Stanley, meanwhile, said their central scenario was for the S&amp;P 500 to end the year at 4400, a drop of 6.9%. They expect price/earnings multiples to fall next year as bond yields rise.</p><p><blockquote>与此同时，摩根士丹利策略师表示，他们的核心预期是标普500年底将跌至4400点，跌幅为6.9%。他们预计，随着债券收益率上升，明年的市盈率将会下降。</blockquote></p><p> Slimmed-down valuations would be especially significant for a stock index such as the S&amp;P 500, since it is&nbsp;driven by big tech stocks&nbsp;that often trade at high multiples.Microsoft&nbsp;Corp.,Nvidia&nbsp;Corp.,Apple&nbsp;Inc.,Alphabet&nbsp;Inc.andTeslaInc.recently accounted for about one-third of the benchmark’s gains this year. Tesla traded last week at about 123 times its projected earnings over the next 12 months, while Nvidia traded at about 58 times.</p><p><blockquote>对于标普500这样的股指来说，估值下调尤其重要，因为它是由大型科技股推动的，这些科技股通常以高市盈率交易。微软公司、英伟达公司、苹果公司、Alphabet公司和特斯拉公司最近约占该基准今年涨幅的三分之一。特斯拉上周的市盈率约为未来12个月预期市盈率的123倍，而英伟达的市盈率约为58倍。</blockquote></p><p> Profits at big U.S. companies are expected to grow next year, though at a slower pace than this year’s surge. Analysts estimate that earnings from S&amp;P 500 companies will rise 9.2% in 2022, according to FactSet, down from the predicted 45% profit growth in 2021.</p><p><blockquote>美国大公司的利润预计明年将增长，尽管增速低于今年的飙升。FactSet的数据显示，分析师预计2022年标普500公司的盈利将增长9.2%，低于2021年45%的利润增长预测。</blockquote></p><p></p><p> Still, many investors said that earnings are a reason to be confident that the market rally can last.</p><p><blockquote>尽管如此，许多投资者表示，盈利是对市场反弹能够持续充满信心的一个理由。</blockquote></p><p> “It’s easy to find a lot of things that can go wrong,” said Steve Kolano, chief investment officer at BNY Mellon Investor Solutions. “At the end of the day, earnings drive the equity markets.”</p><p><blockquote>纽约梅隆银行投资者解决方案首席投资官史蒂夫·科拉诺表示：“很容易发现很多可能出错的地方。”“归根结底，盈利推动股市。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Bets S&P 500 Will Say Goodbye to Outsize Stock Gains in 2022<blockquote>华尔街押注标普500将在2022年告别股价大幅上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Bets S&P 500 Will Say Goodbye to Outsize Stock Gains in 2022<blockquote>华尔街押注标普500将在2022年告别股价大幅上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">WSJ</strong><span class=\"h-time small\">2021-12-27 07:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. stocks are on track to end 2021 with another year of outsize gains. Many investors aren’t expecting a repeat in 2022.</p><p><blockquote>美国股市有望在2021年结束时迎来又一年的大幅上涨。许多投资者预计2022年不会重演。</blockquote></p><p> The S&amp;P 500 has climbed 26% so far in 2021, after rising 16% in 2020. Rip-roaring corporate profits and easy monetary policy have fueled the run. Earnings growth is expected to moderate next year, and the Federal Reserve is pursuing&nbsp;plans to raise interest rates, chipping away at key supports for the stock market’s rally.</p><p><blockquote>标普500在2020年上涨16%后，2021年迄今已上涨26%。飙升的企业利润和宽松的货币政策推动了这一挤兑。预计明年盈利增长将放缓，美联储正在推行加息计划，削弱了股市上涨的关键支撑。</blockquote></p><p> When rates are low, investors tend to load up on risk assets such as stocks to generate returns. When inflation accelerates and policy makers raise interest rates, the value of companies’ future earnings drops and investors have more alternatives for places to make money.</p><p><blockquote>当利率较低时，投资者往往会买入股票等风险资产以产生回报。当通胀加速、政策制定者加息时，公司未来盈利的价值就会下降，投资者就有更多赚钱的选择。</blockquote></p><p> Rock-bottom interest rates early in 2020 helped propel equity valuations higher, and they have remained elevated in the months since. Many analysts and investors now believe that increasing rates are likely to keep valuations from rising further, and might cause them to fall.</p><p><blockquote>2020年初的最低利率帮助推高了股票估值，并且在此后的几个月里一直保持在高位。许多分析师和投资者现在认为，加息可能会阻止估值进一步上升，并可能导致估值下跌。</blockquote></p><p> Though stock indexes often continue to rise early in a cycle of interest-rate increases, tighter monetary policy puts portfolio managers on a shorter leash and makes many of them guarded about taking on more risk.</p><p><blockquote>尽管股指往往在加息周期的早期继续上涨，但收紧的货币政策使投资组合经理受到更短的约束，并使他们中的许多人对承担更多风险持谨慎态度。</blockquote></p><p> “We know there’s going to be a rate hike,” said Tiffany Wade, senior portfolio manager at Columbia Threadneedle Investments. “How soon before that do you start to position around valuations maybe coming off?”</p><p><blockquote>Columbia Threadneedle Investments高级投资组合经理蒂芙尼·韦德(Tiffany Wade)表示：“我们知道将会加息。”“在此之前，你多久会开始围绕估值可能会下降进行定位？”</blockquote></p><p> The S&amp;P 500 traded last week at about 21 times its projected earnings over the next 12 months, above a five-year average of a little less than 19 times, according to FactSet.</p><p><blockquote>FactSet的数据显示，这家标普500上周的市盈率约为未来12个月预期市盈率的21倍，高于略低于19倍的五年平均水平。</blockquote></p><p> Some strategists think the shift in monetary policy could help limit stock gains to levels more in keeping with their long-term trend. The S&amp;P 500 has averaged an annual gain of 8.4% from 1957, the year it was introduced, through last year. But it is coming off three much stronger years. The index jumped 29% in 2019, even more than its advances in 2020 and so far in 2021.</p><p><blockquote>一些策略师认为，货币政策的转变可能有助于将股市涨幅限制在更符合长期趋势的水平。从1957年推出到去年，标普500的平均年增长率为8.4%。但这三年表现强劲得多。该指数在2019年上涨了29%，甚至超过了2020年和2021年迄今为止的涨幅。</blockquote></p><p> “That’s not normal,” said Joseph Amato, president and chief investment officer of equities at asset manager Neuberger Berman. “That’s been an extraordinary period of return, and our expectation is you’re not going to see that kind of market performance in ’22.”</p><p><blockquote>“这不正常，”资产管理公司路博迈(Neuberger Berman)总裁兼首席股票投资官约瑟夫·阿马托(Joseph Amato)表示。“这是一个非凡的回报时期，我们的预期是，22年你不会看到这样的市场表现。”</blockquote></p><p> There is reason, of course, to be humble about stock predictions: Analysts can’t forecast world events, or even how the market will react to them. Many analysts thought stocks would plunge throughout 2020 after the Covid-19 pandemic hit the U.S. A year ago, analysts underestimated the strength of the market’s 2021 rally.</p><p><blockquote>当然，我们有理由对股票预测保持谦虚：分析师无法预测世界事件，甚至无法预测市场对这些事件的反应。许多分析师认为，在Covid-19大流行袭击美国后，股市将在2020年全年暴跌。一年前，分析师低估了市场2021年反弹的力度。</blockquote></p><p> “One year is such a short period that it’s really hard to accurately forecast where stocks will be in a year from now,” said Aneet Chachra, portfolio manager at Janus Henderson Investors.</p><p><blockquote>Janus Henderson Investors投资组合经理Aneet Chachra表示：“一年的时间很短，很难准确预测一年后股市的走势。”</blockquote></p><p> Still, many of the structures that have supported the market will fade next year. Gains in 2020 and 2021 have been propped up by government spending and central-bank interventions, including the near-zero interest rates.</p><p><blockquote>尽管如此，许多支撑市场的结构将在明年消失。2020年和2021年的收益受到政府支出和央行干预（包括接近零的利率）的支撑。</blockquote></p><p> This month the Fed laid the groundwork for&nbsp;interest-rate increases&nbsp;starting as early as next spring and approved plans to wind down a bond-buying stimulus program more quickly. Democrats’ roughly $2 trillion&nbsp;education, healthcare and climate package&nbsp;faces an uncertain future after Sen. Joe Manchin (D., W.Va.) said last week he would oppose it.</p><p><blockquote>本月，美联储为最早于明年春天开始的加息奠定了基础，并批准了更快结束债券购买刺激计划的计划。民主党大约2万亿美元的教育、医疗和气候一揽子计划面临着不确定的未来，此前西弗吉尼亚州民主党参议员乔·曼钦（Joe Manchin）上周表示他将反对该计划。</blockquote></p><p> Wall Street strategists are forecasting smaller gains for the S&amp;P 500 in 2022. Among 13 banks and financial services firms whose analysts have published 2022 forecasts, the average target for the S&amp;P 500 to end next year is 4940, about 4.5% above where the index closed Thursday.</p><p><blockquote>华尔街策略师预测，2022年标普500的涨幅将较小。在分析师已发布2022年预测的13家银行和金融服务公司中，明年结束的标普500的平均目标为4940点，比该指数周四收盘价高出约4.5%。</blockquote></p><p> On the high end of next year’s projections, strategists at BMO Capital Markets are forecasting the S&amp;P 500 will finish 2022 at 5300, 12% above its current level. The BMO team expects company earnings growth will help push stocks higher.</p><p><blockquote>BMO Capital Markets的策略师预测，2022年标普500将达到5300点，比当前水平高出12%。BMO团队预计公司盈利增长将有助于推高股价。</blockquote></p><p> Strategists at Morgan Stanley, meanwhile, said their central scenario was for the S&amp;P 500 to end the year at 4400, a drop of 6.9%. They expect price/earnings multiples to fall next year as bond yields rise.</p><p><blockquote>与此同时，摩根士丹利策略师表示，他们的核心预期是标普500年底将跌至4400点，跌幅为6.9%。他们预计，随着债券收益率上升，明年的市盈率将会下降。</blockquote></p><p> Slimmed-down valuations would be especially significant for a stock index such as the S&amp;P 500, since it is&nbsp;driven by big tech stocks&nbsp;that often trade at high multiples.Microsoft&nbsp;Corp.,Nvidia&nbsp;Corp.,Apple&nbsp;Inc.,Alphabet&nbsp;Inc.andTeslaInc.recently accounted for about one-third of the benchmark’s gains this year. Tesla traded last week at about 123 times its projected earnings over the next 12 months, while Nvidia traded at about 58 times.</p><p><blockquote>对于标普500这样的股指来说，估值下调尤其重要，因为它是由大型科技股推动的，这些科技股通常以高市盈率交易。微软公司、英伟达公司、苹果公司、Alphabet公司和特斯拉公司最近约占该基准今年涨幅的三分之一。特斯拉上周的市盈率约为未来12个月预期市盈率的123倍，而英伟达的市盈率约为58倍。</blockquote></p><p> Profits at big U.S. companies are expected to grow next year, though at a slower pace than this year’s surge. Analysts estimate that earnings from S&amp;P 500 companies will rise 9.2% in 2022, according to FactSet, down from the predicted 45% profit growth in 2021.</p><p><blockquote>美国大公司的利润预计明年将增长，尽管增速低于今年的飙升。FactSet的数据显示，分析师预计2022年标普500公司的盈利将增长9.2%，低于2021年45%的利润增长预测。</blockquote></p><p></p><p> Still, many investors said that earnings are a reason to be confident that the market rally can last.</p><p><blockquote>尽管如此，许多投资者表示，盈利是对市场反弹能够持续充满信心的一个理由。</blockquote></p><p> “It’s easy to find a lot of things that can go wrong,” said Steve Kolano, chief investment officer at BNY Mellon Investor Solutions. “At the end of the day, earnings drive the equity markets.”</p><p><blockquote>纽约梅隆银行投资者解决方案首席投资官史蒂夫·科拉诺表示：“很容易发现很多可能出错的地方。”“归根结底，盈利推动股市。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/wall-street-bets-s-p-500-will-say-goodbye-to-outsize-stock-gains-in-2022-11640514607?mod=hp_lead_pos3\">WSJ</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","NVDA":"英伟达","MSFT":"微软",".SPX":"S&P 500 Index","GOOG":"谷歌"},"source_url":"https://www.wsj.com/articles/wall-street-bets-s-p-500-will-say-goodbye-to-outsize-stock-gains-in-2022-11640514607?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152446317","content_text":"U.S. stocks are on track to end 2021 with another year of outsize gains. Many investors aren’t expecting a repeat in 2022.\nThe S&P 500 has climbed 26% so far in 2021, after rising 16% in 2020. Rip-roaring corporate profits and easy monetary policy have fueled the run. Earnings growth is expected to moderate next year, and the Federal Reserve is pursuing plans to raise interest rates, chipping away at key supports for the stock market’s rally.\nWhen rates are low, investors tend to load up on risk assets such as stocks to generate returns. When inflation accelerates and policy makers raise interest rates, the value of companies’ future earnings drops and investors have more alternatives for places to make money.\nRock-bottom interest rates early in 2020 helped propel equity valuations higher, and they have remained elevated in the months since. Many analysts and investors now believe that increasing rates are likely to keep valuations from rising further, and might cause them to fall.\nThough stock indexes often continue to rise early in a cycle of interest-rate increases, tighter monetary policy puts portfolio managers on a shorter leash and makes many of them guarded about taking on more risk.\n“We know there’s going to be a rate hike,” said Tiffany Wade, senior portfolio manager at Columbia Threadneedle Investments. “How soon before that do you start to position around valuations maybe coming off?”\nThe S&P 500 traded last week at about 21 times its projected earnings over the next 12 months, above a five-year average of a little less than 19 times, according to FactSet.\nSome strategists think the shift in monetary policy could help limit stock gains to levels more in keeping with their long-term trend. The S&P 500 has averaged an annual gain of 8.4% from 1957, the year it was introduced, through last year. But it is coming off three much stronger years. The index jumped 29% in 2019, even more than its advances in 2020 and so far in 2021.\n“That’s not normal,” said Joseph Amato, president and chief investment officer of equities at asset manager Neuberger Berman. “That’s been an extraordinary period of return, and our expectation is you’re not going to see that kind of market performance in ’22.”\nThere is reason, of course, to be humble about stock predictions: Analysts can’t forecast world events, or even how the market will react to them. Many analysts thought stocks would plunge throughout 2020 after the Covid-19 pandemic hit the U.S. A year ago, analysts underestimated the strength of the market’s 2021 rally.\n“One year is such a short period that it’s really hard to accurately forecast where stocks will be in a year from now,” said Aneet Chachra, portfolio manager at Janus Henderson Investors.\nStill, many of the structures that have supported the market will fade next year. Gains in 2020 and 2021 have been propped up by government spending and central-bank interventions, including the near-zero interest rates.\nThis month the Fed laid the groundwork for interest-rate increases starting as early as next spring and approved plans to wind down a bond-buying stimulus program more quickly. Democrats’ roughly $2 trillion education, healthcare and climate package faces an uncertain future after Sen. Joe Manchin (D., W.Va.) said last week he would oppose it.\nWall Street strategists are forecasting smaller gains for the S&P 500 in 2022. Among 13 banks and financial services firms whose analysts have published 2022 forecasts, the average target for the S&P 500 to end next year is 4940, about 4.5% above where the index closed Thursday.\nOn the high end of next year’s projections, strategists at BMO Capital Markets are forecasting the S&P 500 will finish 2022 at 5300, 12% above its current level. The BMO team expects company earnings growth will help push stocks higher.\nStrategists at Morgan Stanley, meanwhile, said their central scenario was for the S&P 500 to end the year at 4400, a drop of 6.9%. They expect price/earnings multiples to fall next year as bond yields rise.\nSlimmed-down valuations would be especially significant for a stock index such as the S&P 500, since it is driven by big tech stocks that often trade at high multiples.Microsoft Corp.,Nvidia Corp.,Apple Inc.,Alphabet Inc.andTeslaInc.recently accounted for about one-third of the benchmark’s gains this year. Tesla traded last week at about 123 times its projected earnings over the next 12 months, while Nvidia traded at about 58 times.\nProfits at big U.S. companies are expected to grow next year, though at a slower pace than this year’s surge. Analysts estimate that earnings from S&P 500 companies will rise 9.2% in 2022, according to FactSet, down from the predicted 45% profit growth in 2021.\nStill, many investors said that earnings are a reason to be confident that the market rally can last.\n“It’s easy to find a lot of things that can go wrong,” said Steve Kolano, chief investment officer at BNY Mellon Investor Solutions. “At the end of the day, earnings drive the equity markets.”","news_type":1,"symbols_score_info":{".SPX":0.9,"GOOG":0.9,"AAPL":0.9,"NVDA":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":2127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698586261,"gmtCreate":1640451141418,"gmtModify":1640451142431,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Cloudy skies[LOL]&nbsp;","listText":"Cloudy skies[LOL]&nbsp;","text":"Cloudy skies[LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698586261","repostId":"2193178191","repostType":4,"isVote":1,"tweetType":1,"viewCount":2738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698310150,"gmtCreate":1640303506313,"gmtModify":1640303506584,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Christmas hype","listText":"Christmas hype","text":"Christmas hype","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698310150","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":2430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691506595,"gmtCreate":1640217482132,"gmtModify":1640217482276,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Omicron go away&nbsp;","listText":"Omicron go away&nbsp;","text":"Omicron go away","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691506595","repostId":"2193113147","repostType":4,"isVote":1,"tweetType":1,"viewCount":2487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691971304,"gmtCreate":1640131725072,"gmtModify":1640131725163,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691971304","repostId":"1114412120","repostType":4,"repost":{"id":"1114412120","kind":"news","pubTimestamp":1640131483,"share":"https://www.laohu8.com/m/news/1114412120?lang=zh_CN&edition=full","pubTime":"2021-12-22 08:04","market":"sg","language":"en","title":"Singapore Stock Market Tipped To Open In The Green<blockquote>新加坡股市有望开盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1114412120","media":"RTTNews","summary":"The Singapore stock market on Tuesday snapped the two-day slide in which it had fallen more than 40 ","content":"<p>The Singapore stock market on Tuesday snapped the two-day slide in which it had fallen more than 40 points or 1.3 percent. The Straits Times Index now sits just above the 3,085-point plateau and it may extend its gains on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过40点或1.3%。海峡时报指数目前略高于3,085点的高位，周三可能会延续涨势。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat on easing Covid concerns and surging oil prices. The European and U.S. markets were up and the Asian bourses are expected to open in similar fashion.</p><p><blockquote>由于Covid担忧缓解和油价飙升，全球对亚洲市场的预测是乐观的。欧洲和美国市场上涨，预计亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the industrials and mixed performances from the financials and properties.</p><p><blockquote>继工业股上涨以及金融和房地产股表现好坏参半后，海指周二小幅收高。</blockquote></p><p> For the day, the index improved 12.11 points or 0.39 percent to finish at 3,085.08 after trading between 3,079.34 and 3,101.75. Volume was 880.3 million shares worth 727.3 million Singapore dollars. There were 255 gainers and 177 decliners.</p><p><blockquote>当天，该指数在3,079.34点至3,101.75点之间交易后，上涨12.11点或0.39%，收于3,085.08点。成交量为8.803亿股，价值7.273亿新元。上涨255家，下跌177家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust dropped 0.51 percent, while City Developments fell 0.15 percent, Comfort DelGro gathered 0.74 percent, Dairy Farm International surged 3.80 percent, DBS Group eased 0.03 percent, Genting Singapore climbed 1.33 percent, Hongkong Land soared 2.76 percent, Keppel Corp jumped 1.39 percent, Mapletree Logistics Trust advanced 1.09 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS perked 0.53 percent, SembCorp Industries spiked 2.05 percent, Singapore Airlines accelerated 1.66 percent, Singapore Exchange rose 0.22 percent, Singapore Press Holdings and SingTel both shed 0.43 percent, Singapore Technologies Engineering rallied 1.37 percent, Thai Beverage sank 0.76 percent, United Overseas Bank was up 0.04 percent, Wilmar International gained 0.25 percent, Yangzijiang Shipbuilding added 0.78 percent and Ascendas REIT, Mapletree Commercial Trust and Venture Corporation were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托下跌0.51%，城市发展下跌0.15%，Comfort DelGro上涨0.74%，Dairy Farm International飙升3.80%，星展集团下跌0.03%，云顶新加坡上涨1.33%，香港置地飙升2.76%，吉宝企业上涨1.39%，丰树物流信托上涨1.09%，华侨银行上涨0.09%，SATS上涨0.53%，胜科工业飙升2.05%，新加坡航空加速1.66%，新加坡交易所上涨0.22%，新加坡科技工程上涨1.37%，泰国饮料下跌0.76%，大华银行上涨0.04%，丰益国际上涨0.25%，扬子江造船上涨0.78%，腾飞房地产投资信托、丰树商业信托和风险投资公司持平。</blockquote></p><p> The lead from Wall Street is solid as the major averages opened higher on Tuesday and accelerated into the close, finishing near daily highs.</p><p><blockquote>华尔街的领先优势稳固，主要股指周二开盘走高，收盘时加速上涨，收于日高点附近。</blockquote></p><p> The Dow surged 560.54 points or 1.60 percent to finish at 35,492.70, while the NASDAQ spiked 360.14 points or 2.40 percent to close at 15,341.09 and the S&amp;P 500 jumped 81.21 points or 1.78 percent to end at 4,649.23.</p><p><blockquote>道琼斯指数飙升560.54点或1.60%，收于35,492.70点；纳斯达克指数飙升360.14点或2.40%，收于15,341.09点；标普500指数上涨81.21点或1.78%，收于4,649.23点。</blockquote></p><p> Bargain hunting contributed to the strength on Wall Street as traders picked up stocks at reduced levels on the heels of recent weakness. Monday's steep drop dragged the tech-heavy NASDAQ to its lowest closing level in over two months.</p><p><blockquote>由于交易员在近期疲软后以较低水平买入股票，逢低买入推动了华尔街的走强。周一的大幅下跌将以科技股为主的纳斯达克拖至两个多月来的最低收盘水平。</blockquote></p><p> The rebound followed a report from Moderna (MRNA) about the effectiveness of a booster dose of its Covid-19 vaccine against the Omicron variant - which said a booster dose of its Covid-19 vaccine increased antibody levels against Omicron.</p><p><blockquote>Moderna(MRNA)发布了一份关于其Covid-19疫苗加强剂量针对奥密克戎变种的有效性的报告，该报告称，其Covid-19疫苗加强剂量增加了针对奥密克戎病毒的抗体水平。</blockquote></p><p> Crude oil futures settled sharply higher Tuesday as prices rebounded from losses in the previous two sessions. West Texas Intermediate Crude oil futures for February ended up by $2.51 or 3.7 percent at $71.12 a barrel.</p><p><blockquote>原油期货周二大幅收高，因价格从前两个交易日的跌幅中反弹。西德克萨斯中质原油2月期货收涨2.51美元或3.7%，报每桶71.12美元。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Tipped To Open In The Green<blockquote>新加坡股市有望开盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Tipped To Open In The Green<blockquote>新加坡股市有望开盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-22 08:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market on Tuesday snapped the two-day slide in which it had fallen more than 40 points or 1.3 percent. The Straits Times Index now sits just above the 3,085-point plateau and it may extend its gains on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过40点或1.3%。海峡时报指数目前略高于3,085点的高位，周三可能会延续涨势。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is upbeat on easing Covid concerns and surging oil prices. The European and U.S. markets were up and the Asian bourses are expected to open in similar fashion.</p><p><blockquote>由于Covid担忧缓解和油价飙升，全球对亚洲市场的预测是乐观的。欧洲和美国市场上涨，预计亚洲股市也将以类似的方式开盘。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the industrials and mixed performances from the financials and properties.</p><p><blockquote>继工业股上涨以及金融和房地产股表现好坏参半后，海指周二小幅收高。</blockquote></p><p> For the day, the index improved 12.11 points or 0.39 percent to finish at 3,085.08 after trading between 3,079.34 and 3,101.75. Volume was 880.3 million shares worth 727.3 million Singapore dollars. There were 255 gainers and 177 decliners.</p><p><blockquote>当天，该指数在3,079.34点至3,101.75点之间交易后，上涨12.11点或0.39%，收于3,085.08点。成交量为8.803亿股，价值7.273亿新元。上涨255家，下跌177家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust dropped 0.51 percent, while City Developments fell 0.15 percent, Comfort DelGro gathered 0.74 percent, Dairy Farm International surged 3.80 percent, DBS Group eased 0.03 percent, Genting Singapore climbed 1.33 percent, Hongkong Land soared 2.76 percent, Keppel Corp jumped 1.39 percent, Mapletree Logistics Trust advanced 1.09 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS perked 0.53 percent, SembCorp Industries spiked 2.05 percent, Singapore Airlines accelerated 1.66 percent, Singapore Exchange rose 0.22 percent, Singapore Press Holdings and SingTel both shed 0.43 percent, Singapore Technologies Engineering rallied 1.37 percent, Thai Beverage sank 0.76 percent, United Overseas Bank was up 0.04 percent, Wilmar International gained 0.25 percent, Yangzijiang Shipbuilding added 0.78 percent and Ascendas REIT, Mapletree Commercial Trust and Venture Corporation were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托下跌0.51%，城市发展下跌0.15%，Comfort DelGro上涨0.74%，Dairy Farm International飙升3.80%，星展集团下跌0.03%，云顶新加坡上涨1.33%，香港置地飙升2.76%，吉宝企业上涨1.39%，丰树物流信托上涨1.09%，华侨银行上涨0.09%，SATS上涨0.53%，胜科工业飙升2.05%，新加坡航空加速1.66%，新加坡交易所上涨0.22%，新加坡科技工程上涨1.37%，泰国饮料下跌0.76%，大华银行上涨0.04%，丰益国际上涨0.25%，扬子江造船上涨0.78%，腾飞房地产投资信托、丰树商业信托和风险投资公司持平。</blockquote></p><p> The lead from Wall Street is solid as the major averages opened higher on Tuesday and accelerated into the close, finishing near daily highs.</p><p><blockquote>华尔街的领先优势稳固，主要股指周二开盘走高，收盘时加速上涨，收于日高点附近。</blockquote></p><p> The Dow surged 560.54 points or 1.60 percent to finish at 35,492.70, while the NASDAQ spiked 360.14 points or 2.40 percent to close at 15,341.09 and the S&amp;P 500 jumped 81.21 points or 1.78 percent to end at 4,649.23.</p><p><blockquote>道琼斯指数飙升560.54点或1.60%，收于35,492.70点；纳斯达克指数飙升360.14点或2.40%，收于15,341.09点；标普500指数上涨81.21点或1.78%，收于4,649.23点。</blockquote></p><p> Bargain hunting contributed to the strength on Wall Street as traders picked up stocks at reduced levels on the heels of recent weakness. Monday's steep drop dragged the tech-heavy NASDAQ to its lowest closing level in over two months.</p><p><blockquote>由于交易员在近期疲软后以较低水平买入股票，逢低买入推动了华尔街的走强。周一的大幅下跌将以科技股为主的纳斯达克拖至两个多月来的最低收盘水平。</blockquote></p><p> The rebound followed a report from Moderna (MRNA) about the effectiveness of a booster dose of its Covid-19 vaccine against the Omicron variant - which said a booster dose of its Covid-19 vaccine increased antibody levels against Omicron.</p><p><blockquote>Moderna(MRNA)发布了一份关于其Covid-19疫苗加强剂量针对奥密克戎变种的有效性的报告，该报告称，其Covid-19疫苗加强剂量增加了针对奥密克戎病毒的抗体水平。</blockquote></p><p> Crude oil futures settled sharply higher Tuesday as prices rebounded from losses in the previous two sessions. West Texas Intermediate Crude oil futures for February ended up by $2.51 or 3.7 percent at $71.12 a barrel.</p><p><blockquote>原油期货周二大幅收高，因价格从前两个交易日的跌幅中反弹。西德克萨斯中质原油2月期货收涨2.51美元或3.7%，报每桶71.12美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3250922/singapore-stock-market-tipped-to-open-in-the-green.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3250922/singapore-stock-market-tipped-to-open-in-the-green.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114412120","content_text":"The Singapore stock market on Tuesday snapped the two-day slide in which it had fallen more than 40 points or 1.3 percent. The Straits Times Index now sits just above the 3,085-point plateau and it may extend its gains on Wednesday.\nThe global forecast for the Asian markets is upbeat on easing Covid concerns and surging oil prices. The European and U.S. markets were up and the Asian bourses are expected to open in similar fashion.\nThe STI finished modestly higher on Tuesday following gains from the industrials and mixed performances from the financials and properties.\nFor the day, the index improved 12.11 points or 0.39 percent to finish at 3,085.08 after trading between 3,079.34 and 3,101.75. Volume was 880.3 million shares worth 727.3 million Singapore dollars. There were 255 gainers and 177 decliners.\nAmong the actives, CapitaLand Integrated Commercial Trust dropped 0.51 percent, while City Developments fell 0.15 percent, Comfort DelGro gathered 0.74 percent, Dairy Farm International surged 3.80 percent, DBS Group eased 0.03 percent, Genting Singapore climbed 1.33 percent, Hongkong Land soared 2.76 percent, Keppel Corp jumped 1.39 percent, Mapletree Logistics Trust advanced 1.09 percent, Oversea-Chinese Banking Corporation collected 0.09 percent, SATS perked 0.53 percent, SembCorp Industries spiked 2.05 percent, Singapore Airlines accelerated 1.66 percent, Singapore Exchange rose 0.22 percent, Singapore Press Holdings and SingTel both shed 0.43 percent, Singapore Technologies Engineering rallied 1.37 percent, Thai Beverage sank 0.76 percent, United Overseas Bank was up 0.04 percent, Wilmar International gained 0.25 percent, Yangzijiang Shipbuilding added 0.78 percent and Ascendas REIT, Mapletree Commercial Trust and Venture Corporation were unchanged.\nThe lead from Wall Street is solid as the major averages opened higher on Tuesday and accelerated into the close, finishing near daily highs.\nThe Dow surged 560.54 points or 1.60 percent to finish at 35,492.70, while the NASDAQ spiked 360.14 points or 2.40 percent to close at 15,341.09 and the S&P 500 jumped 81.21 points or 1.78 percent to end at 4,649.23.\nBargain hunting contributed to the strength on Wall Street as traders picked up stocks at reduced levels on the heels of recent weakness. Monday's steep drop dragged the tech-heavy NASDAQ to its lowest closing level in over two months.\nThe rebound followed a report from Moderna (MRNA) about the effectiveness of a booster dose of its Covid-19 vaccine against the Omicron variant - which said a booster dose of its Covid-19 vaccine increased antibody levels against Omicron.\nCrude oil futures settled sharply higher Tuesday as prices rebounded from losses in the previous two sessions. West Texas Intermediate Crude oil futures for February ended up by $2.51 or 3.7 percent at $71.12 a barrel.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":2484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693438162,"gmtCreate":1640058771445,"gmtModify":1640059673375,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"No way home","listText":"No way home","text":"No way home","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693438162","repostId":"1148092447","repostType":4,"repost":{"id":"1148092447","kind":"news","pubTimestamp":1640057971,"share":"https://www.laohu8.com/m/news/1148092447?lang=zh_CN&edition=full","pubTime":"2021-12-21 11:39","market":"us","language":"en","title":"Disney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148092447","media":"Investopedia","summary":"Box-office success of latest installment suggests merchandise sales opportunity","content":"<p><b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>The latest installment in the Spiderman franchise is setting box-office records.</li>  <li>Disney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.</li>  <li>Typically, merchandise sales for Spiderman movies track box-office performance.</li> </ul> In a bit of welcome news for the beleaguered entertainment industry,<i>Spider-Man: No Way Home</i>, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind&nbsp;<i>Avengers: Endgame</i>&nbsp;and&nbsp;<i>Avengers: Infinity War</i>.</p><p><blockquote><ul><li>蜘蛛侠系列的最新一部正在创造票房记录。</li><li>迪士尼不会从索尼制作的蜘蛛侠电影的票房收入中获利，但会从商品销售中获利。</li><li>通常，蜘蛛侠电影的商品销售会跟踪票房表现。</li></ul>对于陷入困境的娱乐业来说，这是个好消息。<i>蜘蛛侠：英雄无归</i>漫威电影宇宙（MCU）的最新电影，上周末票房大卖。据报道，这部电影在国内获得了2.53亿美元的票房，是2021年首映的最高票房。它还从海外市场获得了3.342亿美元的票房，总票房为5.872亿美元，成为有史以来第三好的首映票房，仅次于<i>复仇者联盟：终局之战</i>和<i>复仇者联盟3：无限战争</i>.</blockquote></p><p> But The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.</p><p><blockquote>但拥有MCU的华特迪士尼公司（DIS）可能不会从最新蜘蛛侠电影的票房收入中赚到一分钱。相反，该公司从漫威合资企业中获得的利润来源将来自商品销售。</blockquote></p><p> <b>A Spidey Partnership</b></p><p><blockquote><b>蜘蛛侠伙伴关系</b></blockquote></p><p> Even though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company&nbsp;purchased the rights&nbsp;to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.</p><p><blockquote>尽管蜘蛛侠是迪士尼旗下MCU的一部分，但以彼得·帕克为主角的电影是由索尼集团公司（Sony）制作的。这家总部位于东京的公司早在1999年就购买了web slinger的版权，当时漫威还是一个独立的实体。作为购买协议的一部分，漫威从索尼制作和发行的电影中获得总票房的5%，而两家公司则平分商品收入。</blockquote></p><p> The terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.</p><p><blockquote>这种合作关系的条款在2011年发生了变化。漫威已经在2009年被迪士尼收购。2011年急需现金的索尼修改了协议，放弃了其商品销售份额，而迪士尼则放弃了其票房收入份额。</blockquote></p><p> Typically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of&nbsp;<i>Spiderman 3</i>&nbsp;in 2007. But they fell to $200 million after the unsuccessful debut of&nbsp;<i>The Amazing Spiderman 2</i>&nbsp;in 2014.2</p><p><blockquote>通常，蜘蛛侠系列的商品销售会跟踪票房收入。蜘蛛侠电影越成功，其商品销量就越大。例如，在大片上映后，商品销售额总计3.97亿美元。<i>蜘蛛侠3</i>2007年。但在首次亮相不成功后，他们的收入跌至2亿美元<i>超凡蜘蛛侠2</i>于2014.2</blockquote></p><p> Even during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.</p><p><blockquote>即使在销售低迷的时候，就商品销售而言，蜘蛛侠也是一个摇钱树。到2014年，与该动作玩偶相关的全球零售额估计为每年13亿美元，使蜘蛛侠成为最成功的系列。</blockquote></p><p> The equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.</p><p><blockquote>商品销售和票房表现之间的等式预示着迪士尼从最新一期《蜘蛛侠》中获得的利润。它的元宇宙主题跨越了不同的时间线和角色，也为来自过去和现在的特许经营不同阶段的角色提供了许多许可机会。根据License Global杂志的数据，House of Mouse是2018年全球最大的授权商，全球授权商品零售额为547亿美元。</blockquote></p><p></p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investopedia</strong><span class=\"h-time small\">2021-12-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>The latest installment in the Spiderman franchise is setting box-office records.</li>  <li>Disney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.</li>  <li>Typically, merchandise sales for Spiderman movies track box-office performance.</li> </ul> In a bit of welcome news for the beleaguered entertainment industry,<i>Spider-Man: No Way Home</i>, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind&nbsp;<i>Avengers: Endgame</i>&nbsp;and&nbsp;<i>Avengers: Infinity War</i>.</p><p><blockquote><ul><li>蜘蛛侠系列的最新一部正在创造票房记录。</li><li>迪士尼不会从索尼制作的蜘蛛侠电影的票房收入中获利，但会从商品销售中获利。</li><li>通常，蜘蛛侠电影的商品销售会跟踪票房表现。</li></ul>对于陷入困境的娱乐业来说，这是个好消息。<i>蜘蛛侠：英雄无归</i>漫威电影宇宙（MCU）的最新电影，上周末票房大卖。据报道，这部电影在国内获得了2.53亿美元的票房，是2021年首映的最高票房。它还从海外市场获得了3.342亿美元的票房，总票房为5.872亿美元，成为有史以来第三好的首映票房，仅次于<i>复仇者联盟：终局之战</i>和<i>复仇者联盟3：无限战争</i>.</blockquote></p><p> But The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.</p><p><blockquote>但拥有MCU的华特迪士尼公司（DIS）可能不会从最新蜘蛛侠电影的票房收入中赚到一分钱。相反，该公司从漫威合资企业中获得的利润来源将来自商品销售。</blockquote></p><p> <b>A Spidey Partnership</b></p><p><blockquote><b>蜘蛛侠伙伴关系</b></blockquote></p><p> Even though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company&nbsp;purchased the rights&nbsp;to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.</p><p><blockquote>尽管蜘蛛侠是迪士尼旗下MCU的一部分，但以彼得·帕克为主角的电影是由索尼集团公司（Sony）制作的。这家总部位于东京的公司早在1999年就购买了web slinger的版权，当时漫威还是一个独立的实体。作为购买协议的一部分，漫威从索尼制作和发行的电影中获得总票房的5%，而两家公司则平分商品收入。</blockquote></p><p> The terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.</p><p><blockquote>这种合作关系的条款在2011年发生了变化。漫威已经在2009年被迪士尼收购。2011年急需现金的索尼修改了协议，放弃了其商品销售份额，而迪士尼则放弃了其票房收入份额。</blockquote></p><p> Typically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of&nbsp;<i>Spiderman 3</i>&nbsp;in 2007. But they fell to $200 million after the unsuccessful debut of&nbsp;<i>The Amazing Spiderman 2</i>&nbsp;in 2014.2</p><p><blockquote>通常，蜘蛛侠系列的商品销售会跟踪票房收入。蜘蛛侠电影越成功，其商品销量就越大。例如，在大片上映后，商品销售额总计3.97亿美元。<i>蜘蛛侠3</i>2007年。但在首次亮相不成功后，他们的收入跌至2亿美元<i>超凡蜘蛛侠2</i>于2014.2</blockquote></p><p> Even during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.</p><p><blockquote>即使在销售低迷的时候，就商品销售而言，蜘蛛侠也是一个摇钱树。到2014年，与该动作玩偶相关的全球零售额估计为每年13亿美元，使蜘蛛侠成为最成功的系列。</blockquote></p><p> The equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.</p><p><blockquote>商品销售和票房表现之间的等式预示着迪士尼从最新一期《蜘蛛侠》中获得的利润。它的元宇宙主题跨越了不同的时间线和角色，也为来自过去和现在的特许经营不同阶段的角色提供了许多许可机会。根据License Global杂志的数据，House of Mouse是2018年全球最大的授权商，全球授权商品零售额为547亿美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investopedia.com/disney-could-profit-from-spiderman-merchandise-5213902\">Investopedia</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"https://www.investopedia.com/disney-could-profit-from-spiderman-merchandise-5213902","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148092447","content_text":"KEY TAKEAWAYS\n\nThe latest installment in the Spiderman franchise is setting box-office records.\nDisney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.\nTypically, merchandise sales for Spiderman movies track box-office performance.\n\nIn a bit of welcome news for the beleaguered entertainment industry,Spider-Man: No Way Home, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind Avengers: Endgame and Avengers: Infinity War.\nBut The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.\nA Spidey Partnership\nEven though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company purchased the rights to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.\nThe terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.\nTypically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of Spiderman 3 in 2007. But they fell to $200 million after the unsuccessful debut of The Amazing Spiderman 2 in 2014.2\nEven during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.\nThe equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.","news_type":1,"symbols_score_info":{"DIS":0.9}},"isVote":1,"tweetType":1,"viewCount":2432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693395875,"gmtCreate":1639968225496,"gmtModify":1639968225582,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Interesting list of stocks, including Unity and UiPath","listText":"Interesting list of stocks, including Unity and UiPath","text":"Interesting list of stocks, including Unity and UiPath","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693395875","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":2819,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699418865,"gmtCreate":1639875630158,"gmtModify":1639875630277,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Let's go up up up","listText":"Let's go up up up","text":"Let's go up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699418865","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=zh_CN&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-18 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":2308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690410169,"gmtCreate":1639700487566,"gmtModify":1639700487661,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Soon Apple will not be reliant on Intel and Qualcomm anymore&nbsp;","listText":"Soon Apple will not be reliant on Intel and Qualcomm anymore&nbsp;","text":"Soon Apple will not be reliant on Intel and Qualcomm anymore","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690410169","repostId":"2192941918","repostType":4,"isVote":1,"tweetType":1,"viewCount":1157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607773751,"gmtCreate":1639610087948,"gmtModify":1639610088044,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Amazing how the market turned green with the news and expectations of this","listText":"Amazing how the market turned green with the news and expectations of this","text":"Amazing how the market turned green with the news and expectations of this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607773751","repostId":"1172651405","repostType":4,"repost":{"id":"1172651405","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639595340,"share":"https://www.laohu8.com/m/news/1172651405?lang=zh_CN&edition=full","pubTime":"2021-12-16 03:09","market":"us","language":"en","title":"Dow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172651405","media":"Tiger Newspress","summary":"U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve he","content":"<p>U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. </p><p><blockquote>周三下午，美国股市基准小幅走高，美联储一如预期维持利率稳定，但加快了缩减债券购买计划的步伐，为2022年上半年加息打开了大门。</blockquote></p><p> Projections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. </p><p><blockquote>美联储预计明年将加息三次，目前联邦基金利率在0%至0.25%之间。美联储主席杰罗姆·鲍威尔将于美国东部时间下午2:30召开新闻发布会，讨论央行的最新政策。</blockquote></p><p> The move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. </p><p><blockquote>比官员们上个月会议上计划的更早结束刺激计划的举动提供了最具体的迹象，表明鲍威尔的重点已转向防止通胀上升变得根深蒂固。</blockquote></p><p> But the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. </p><p><blockquote>但更新后的政策出台之际，冠状病毒的奥密克戎变种导致了COVID-19的传播，引发了人们对经济复苏和供应链瓶颈的新担忧，这些瓶颈有助于支撑通胀上升。</blockquote></p><p> The Dow Jones Industrial Average&nbsp;popped into positive territory, up 0.3% at 35,645, the S&amp;P 500 index&nbsp;climbed 0.3% to 4,650, and the Nasdaq Composite Index&nbsp;briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note&nbsp;yields 1.46% from around 1.44% before the Fed update.</p><p><blockquote>道琼斯工业平均指数上涨0.3%，至35,645点，标普500指数上涨0.3%，至4,650点，纳斯达克综合指数短暂上涨不到0.1%，至15,269点。10年期国债收益率从美联储更新前的1.44%左右升至1.46%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 03:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. </p><p><blockquote>周三下午，美国股市基准小幅走高，美联储一如预期维持利率稳定，但加快了缩减债券购买计划的步伐，为2022年上半年加息打开了大门。</blockquote></p><p> Projections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. </p><p><blockquote>美联储预计明年将加息三次，目前联邦基金利率在0%至0.25%之间。美联储主席杰罗姆·鲍威尔将于美国东部时间下午2:30召开新闻发布会，讨论央行的最新政策。</blockquote></p><p> The move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. </p><p><blockquote>比官员们上个月会议上计划的更早结束刺激计划的举动提供了最具体的迹象，表明鲍威尔的重点已转向防止通胀上升变得根深蒂固。</blockquote></p><p> But the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. </p><p><blockquote>但更新后的政策出台之际，冠状病毒的奥密克戎变种导致了COVID-19的传播，引发了人们对经济复苏和供应链瓶颈的新担忧，这些瓶颈有助于支撑通胀上升。</blockquote></p><p> The Dow Jones Industrial Average&nbsp;popped into positive territory, up 0.3% at 35,645, the S&amp;P 500 index&nbsp;climbed 0.3% to 4,650, and the Nasdaq Composite Index&nbsp;briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note&nbsp;yields 1.46% from around 1.44% before the Fed update.</p><p><blockquote>道琼斯工业平均指数上涨0.3%，至35,645点，标普500指数上涨0.3%，至4,650点，纳斯达克综合指数短暂上涨不到0.1%，至15,269点。10年期国债收益率从美联储更新前的1.44%左右升至1.46%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172651405","content_text":"U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. \nProjections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. \nThe move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. \nBut the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. \nThe Dow Jones Industrial Average popped into positive territory, up 0.3% at 35,645, the S&P 500 index climbed 0.3% to 4,650, and the Nasdaq Composite Index briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note yields 1.46% from around 1.44% before the Fed update.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607812179,"gmtCreate":1639524492603,"gmtModify":1639524492603,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607812179","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607818300,"gmtCreate":1639524333714,"gmtModify":1639524389383,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Continue to rise&nbsp;<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>","listText":"Continue to rise&nbsp;<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>","text":"Continue to rise $Apple(AAPL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607818300","repostId":"1155236279","repostType":4,"isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607813789,"gmtCreate":1639524197243,"gmtModify":1639524385259,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Wonder how is Moderna's trial with Omicron","listText":"Wonder how is Moderna's trial with Omicron","text":"Wonder how is Moderna's trial with Omicron","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607813789","repostId":"1111446051","repostType":4,"repost":{"id":"1111446051","kind":"news","pubTimestamp":1639523229,"share":"https://www.laohu8.com/m/news/1111446051?lang=zh_CN&edition=full","pubTime":"2021-12-15 07:07","market":"us","language":"en","title":"Pfizer Says Its Covid-19 Pill Likely Works Against Omicron<blockquote>辉瑞表示其Covid-19药物可能对奥密克戎病毒有效</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1111446051","media":"The Wall Street Journal","summary":"Preliminary laboratory tests gave encouraging signs that Pfizer Inc.’s PFE 0.62% experimental Covid-","content":"<p> Preliminary laboratory tests gave encouraging signs that Pfizer Inc.’s PFE 0.62% experimental Covid-19 pill for the newly infected could work against Omicron, the company said.</p><p><blockquote>辉瑞公司表示，初步实验室测试给出了令人鼓舞的迹象，表明针对新感染者的PFE 0.62%实验性Covid-19药丸可能对奥密克戎病毒有效。</blockquote></p><p> Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective at reducing the risk of hospitalization and death in adults at high risk of severe Covid-19.</p><p><blockquote>辉瑞周二还表示，对后期研究结果的最终分析证实，这种名为Paxlovid的药物在降低严重Covid-19高风险成年人的住院和死亡风险方面有89%的有效性。</blockquote></p><p> The positive results come as the Food and Drug Administration reviews whether to clear use of Paxlovid in high-risk adults, a decision that could come before the end of the year.</p><p><blockquote>这一积极结果出现之际，美国食品和药物管理局正在审查是否批准在高危成年人中使用Paxlovid，这一决定可能会在今年年底前做出。</blockquote></p><p> “This was a real home run, gives tremendous hope for another highly effective intervention,” Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p><p><blockquote>辉瑞首席科学官米凯尔·多尔斯滕(Mikael Dolsten)在接受采访时表示：“这是一次真正的本垒打，为另一种高效干预措施带来了巨大希望。”</blockquote></p><p> Meanwhile, a separate, preliminary analysis provided signs the drug may help people at low risk of severe Covid-19, such as vaccinated individuals who end up becoming sick.</p><p><blockquote>与此同时，一项单独的初步分析表明，该药物可能有助于严重Covid-19风险较低的人，例如最终患病的接种疫苗的人。</blockquote></p><p> Paxlovid in the early study analysis reduced the risk of hospitalization and death by 70% in adults at low risk of severe Covid-19, though it failed to reduce or resolve their symptoms within four days.</p><p><blockquote>早期研究分析中的Paxlovid将严重新冠肺炎低风险成年人的住院和死亡风险降低了70%，尽管它未能在四天内减轻或解决他们的症状。</blockquote></p><p> Study subjects who were at high risk of developing severe disease had to have at least one characteristic or underlying health condition such as being obese or elderly. The other study included people who were either unvaccinated and at low risk of developing severe disease, such as young and healthy individuals, or vaccinated people with at least one risk factor for developing severe disease.</p><p><blockquote>具有发生严重疾病高风险的研究受试者必须具有至少一种特征性或潜在健康状况，例如肥胖或老年。另一项研究包括未接种疫苗且患严重疾病风险低的人，如年轻健康的人，或至少有一种患严重疾病风险因素的接种疫苗的人。</blockquote></p><p> Both studies testing Paxlovid in people showed that the amount of virus, or viral load, in subjects who received the drug was significantly less than in the placebo groups, Pfizer said.</p><p><blockquote>辉瑞表示，两项在人体中测试Paxlovid的研究都表明，接受该药物的受试者的病毒量或病毒载量明显低于安慰剂组。</blockquote></p><p> A lower viral load could mean less transmission of the virus.</p><p><blockquote>较低的病毒载量可能意味着较少的病毒传播。</blockquote></p><p> Citing the findings, some analysts said Paxlovid was likely to become the Covid-19 drug of choice for newly infected adults seeking to avoid severe disease. JP Morgan Chase &amp; Co. analysts estimated $18 billion in sales next year.</p><p><blockquote>一些分析师援引研究结果表示，Paxlovid很可能成为寻求避免严重疾病的新感染成年人的首选Covid-19药物。摩根大通分析师预计明年的销售额将达到180亿美元。</blockquote></p><p> Pfizer shares rose 0.62% in Tuesday trading.</p><p><blockquote>辉瑞股价在周二交易中上涨0.62%。</blockquote></p><p> Doctors and health experts have been looking for an antiviral like Paxlovid, which people could easily take at home within several days of symptoms emerging to prevent their cases from turning serious and requiring hospitalization.</p><p><blockquote>医生和健康专家一直在寻找一种像Paxlovid这样的抗病毒药物，人们可以在症状出现后几天内轻松在家服用，以防止病情变得严重并需要住院治疗。</blockquote></p><p> The emergence of Omicron has shadowed the approach of such antivirals, however, because of uncertainty whether the new strain could elude treatments and vaccines.</p><p><blockquote>然而，奥密克戎病毒的出现给此类抗病毒药物的应用蒙上了阴影，因为不确定这种新毒株是否会逃避治疗和疫苗。</blockquote></p><p> To make an assessment, drugmakers have been studying whether authorized and experimental Covid-19 drugs and vaccines are effective against Omicron.</p><p><blockquote>为了做出评估，制药商一直在研究授权和实验性的Covid-19药物和疫苗是否对奥密克戎有效。</blockquote></p><p> Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ</p><p><blockquote>医生越来越多地转向单克隆抗体药物来治疗感染Covid-19的高危患者。《华尔街日报》着眼于这些疗法是如何工作的，以及为什么它们对拯救生命很重要。插图：雅各布·雷诺兹/《华尔街日报》</blockquote></p><p> Researchers suspected Pfizer’s pill would hold up well because it stops the virus by blocking the activity of a key enzyme, known as protease, that the virus needs to replicate and isn’t believed to be mutated in Omicron.</p><p><blockquote>研究人员怀疑辉瑞的药丸会很有效，因为它通过阻断一种称为蛋白酶的关键酶的活性来阻止病毒，这种酶是病毒复制所需的，并且据信不会在奥密克戎病毒中发生突变。</blockquote></p><p> That is different from Covid-19 vaccines and some treatments that target a different part of the virus, the spike protein, that is the site of many Omicron mutations.</p><p><blockquote>这不同于Covid-19疫苗和一些针对病毒不同部分（刺突蛋白）的治疗方法，刺突蛋白是许多奥密克戎突变的位点。</blockquote></p><p> The early Pfizer laboratory tests showed that Paxlovid blocked the protease enzyme in Omicron, as well as other variants of concern, Dr. Dolsten said.</p><p><blockquote>Dolsten博士说，辉瑞实验室的早期测试表明，Paxlovid阻断了奥密克戎病以及其他令人担忧的变异体中的蛋白酶。</blockquote></p><p> “Without the protease functioning, the virus can’t replicate and cause disease,” Dr. Dolsten said. “I’m very convinced that the effects on Omicron by Paxlovid will be very substantial.”</p><p><blockquote>“如果蛋白酶不发挥作用，病毒就无法复制并导致疾病，”多尔斯滕博士说。“我非常相信Paxlovid对奥密克戎病的影响将是非常大的。”</blockquote></p><p> Pfizer said it plans on performing more testing to measure Paxlovid’s effectiveness against the variant.</p><p><blockquote>辉瑞表示，计划进行更多测试来衡量Paxlovid对该变种的有效性。</blockquote></p><p> In November, Pfizer said an early look at a key study found Paxlovid was 89% effective at reducing the risk of hospitalization and death in high-risk adults.</p><p><blockquote>11月，辉瑞表示，对一项关键研究的早期观察发现，Paxlovid在降低高危成人住院和死亡风险方面的有效性为89%。</blockquote></p><p> The FDA has been waiting for the final results before making an authorization decision, Pfizer Chief Executive Albert Bourla said last week at The Wall Street Journal’s CEO Council.</p><p><blockquote>辉瑞首席执行官Albert Bourla上周在《华尔街日报》首席执行官委员会上表示，FDA一直在等待最终结果，然后再做出授权决定。</blockquote></p><p> In the final analysis, five of the 697 high-risk subjects who received the drug within three days of symptoms were hospitalized or died from Covid-19, compared with 44 out of 682 subjects who received a placebo, Pfizer said.</p><p><blockquote>辉瑞表示，最终分析中，在出现症状三天内接受该药物治疗的697名高危受试者中有5人住院或死于Covid-19，而接受安慰剂治疗的682名受试者中有44人住院或死于Covid-19。</blockquote></p><p> Nine study volunteers who received a placebo died, compared with none in the treatment arm, the company said.</p><p><blockquote>该公司表示，接受安慰剂的研究志愿者中有9人死亡，而治疗组中没有一人死亡。</blockquote></p><p> Researchers also reported the drug was 88% effective if taken within five days of symptoms.</p><p><blockquote>研究人员还报告说，如果在症状出现后五天内服用，该药物的有效率为88%。</blockquote></p><p> The final study analysis of another oral antiviral, from Merck &amp; Co. and partner Ridgeback Biotherapeutics LP, showed a 30% risk reduction, lower than the 50% found during an early look.</p><p><blockquote>默克公司和合作伙伴Ridgeback Biotherapeutics LP对另一种口服抗病毒药物的最终研究分析显示，风险降低了30%，低于早期研究中发现的50%。</blockquote></p><p> Separately, Pfizer has been testing Paxlovid’s effectiveness in people at low risk of developing severe disease, including some who were vaccinated.</p><p><blockquote>另外，辉瑞一直在测试Paxlovid在患严重疾病风险低的人群中的有效性，包括一些接种过疫苗的人。</blockquote></p><p></p><p> The company’s preliminary look at the results found Paxlovid failed to resolve or consistently reduce self-reported symptoms within four days, which was the study’s main goal and a way of determining whether an antiviral is effective.</p><p><blockquote>该公司对结果的初步研究发现，Paxlovid未能在四天内解决或持续减轻自我报告的症状，这是该研究的主要目标，也是确定抗病毒药物是否有效的一种方法。</blockquote></p><p> Two of the 333 low-risk subjects who got Paxlovid were hospitalized, however, compared with eight of 329 subjects who received a placebo, resulting in the 70% efficacy, Pfizer said.</p><p><blockquote>然而，辉瑞表示，接受Paxlovid的333名低风险受试者中有2名住院，而接受安慰剂的329名受试者中有8名住院，有效率为70%。</blockquote></p><p> No subjects had died from Covid-19 in the analysis, which looked at how about 45% of the total number of subjects targeted for the study fared.</p><p><blockquote>在分析中，没有受试者死于Covid-19，该分析考察了该研究目标受试者总数中约45%的受试者的表现。</blockquote></p><p> Dr. Dolsten said Pfizer planned to discuss with health authorities in the U.S. and other countries about potentially making the drug available to low-risk people, and whether Pfizer should do more testing.</p><p><blockquote>多尔斯滕博士表示，辉瑞计划与美国和其他国家的卫生当局讨论向低风险人群提供该药物的可能性，以及辉瑞是否应该进行更多测试。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Says Its Covid-19 Pill Likely Works Against Omicron<blockquote>辉瑞表示其Covid-19药物可能对奥密克戎病毒有效</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Says Its Covid-19 Pill Likely Works Against Omicron<blockquote>辉瑞表示其Covid-19药物可能对奥密克戎病毒有效</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-12-15 07:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p> Preliminary laboratory tests gave encouraging signs that Pfizer Inc.’s PFE 0.62% experimental Covid-19 pill for the newly infected could work against Omicron, the company said.</p><p><blockquote>辉瑞公司表示，初步实验室测试给出了令人鼓舞的迹象，表明针对新感染者的PFE 0.62%实验性Covid-19药丸可能对奥密克戎病毒有效。</blockquote></p><p> Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective at reducing the risk of hospitalization and death in adults at high risk of severe Covid-19.</p><p><blockquote>辉瑞周二还表示，对后期研究结果的最终分析证实，这种名为Paxlovid的药物在降低严重Covid-19高风险成年人的住院和死亡风险方面有89%的有效性。</blockquote></p><p> The positive results come as the Food and Drug Administration reviews whether to clear use of Paxlovid in high-risk adults, a decision that could come before the end of the year.</p><p><blockquote>这一积极结果出现之际，美国食品和药物管理局正在审查是否批准在高危成年人中使用Paxlovid，这一决定可能会在今年年底前做出。</blockquote></p><p> “This was a real home run, gives tremendous hope for another highly effective intervention,” Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p><p><blockquote>辉瑞首席科学官米凯尔·多尔斯滕(Mikael Dolsten)在接受采访时表示：“这是一次真正的本垒打，为另一种高效干预措施带来了巨大希望。”</blockquote></p><p> Meanwhile, a separate, preliminary analysis provided signs the drug may help people at low risk of severe Covid-19, such as vaccinated individuals who end up becoming sick.</p><p><blockquote>与此同时，一项单独的初步分析表明，该药物可能有助于严重Covid-19风险较低的人，例如最终患病的接种疫苗的人。</blockquote></p><p> Paxlovid in the early study analysis reduced the risk of hospitalization and death by 70% in adults at low risk of severe Covid-19, though it failed to reduce or resolve their symptoms within four days.</p><p><blockquote>早期研究分析中的Paxlovid将严重新冠肺炎低风险成年人的住院和死亡风险降低了70%，尽管它未能在四天内减轻或解决他们的症状。</blockquote></p><p> Study subjects who were at high risk of developing severe disease had to have at least one characteristic or underlying health condition such as being obese or elderly. The other study included people who were either unvaccinated and at low risk of developing severe disease, such as young and healthy individuals, or vaccinated people with at least one risk factor for developing severe disease.</p><p><blockquote>具有发生严重疾病高风险的研究受试者必须具有至少一种特征性或潜在健康状况，例如肥胖或老年。另一项研究包括未接种疫苗且患严重疾病风险低的人，如年轻健康的人，或至少有一种患严重疾病风险因素的接种疫苗的人。</blockquote></p><p> Both studies testing Paxlovid in people showed that the amount of virus, or viral load, in subjects who received the drug was significantly less than in the placebo groups, Pfizer said.</p><p><blockquote>辉瑞表示，两项在人体中测试Paxlovid的研究都表明，接受该药物的受试者的病毒量或病毒载量明显低于安慰剂组。</blockquote></p><p> A lower viral load could mean less transmission of the virus.</p><p><blockquote>较低的病毒载量可能意味着较少的病毒传播。</blockquote></p><p> Citing the findings, some analysts said Paxlovid was likely to become the Covid-19 drug of choice for newly infected adults seeking to avoid severe disease. JP Morgan Chase &amp; Co. analysts estimated $18 billion in sales next year.</p><p><blockquote>一些分析师援引研究结果表示，Paxlovid很可能成为寻求避免严重疾病的新感染成年人的首选Covid-19药物。摩根大通分析师预计明年的销售额将达到180亿美元。</blockquote></p><p> Pfizer shares rose 0.62% in Tuesday trading.</p><p><blockquote>辉瑞股价在周二交易中上涨0.62%。</blockquote></p><p> Doctors and health experts have been looking for an antiviral like Paxlovid, which people could easily take at home within several days of symptoms emerging to prevent their cases from turning serious and requiring hospitalization.</p><p><blockquote>医生和健康专家一直在寻找一种像Paxlovid这样的抗病毒药物，人们可以在症状出现后几天内轻松在家服用，以防止病情变得严重并需要住院治疗。</blockquote></p><p> The emergence of Omicron has shadowed the approach of such antivirals, however, because of uncertainty whether the new strain could elude treatments and vaccines.</p><p><blockquote>然而，奥密克戎病毒的出现给此类抗病毒药物的应用蒙上了阴影，因为不确定这种新毒株是否会逃避治疗和疫苗。</blockquote></p><p> To make an assessment, drugmakers have been studying whether authorized and experimental Covid-19 drugs and vaccines are effective against Omicron.</p><p><blockquote>为了做出评估，制药商一直在研究授权和实验性的Covid-19药物和疫苗是否对奥密克戎有效。</blockquote></p><p> Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ</p><p><blockquote>医生越来越多地转向单克隆抗体药物来治疗感染Covid-19的高危患者。《华尔街日报》着眼于这些疗法是如何工作的，以及为什么它们对拯救生命很重要。插图：雅各布·雷诺兹/《华尔街日报》</blockquote></p><p> Researchers suspected Pfizer’s pill would hold up well because it stops the virus by blocking the activity of a key enzyme, known as protease, that the virus needs to replicate and isn’t believed to be mutated in Omicron.</p><p><blockquote>研究人员怀疑辉瑞的药丸会很有效，因为它通过阻断一种称为蛋白酶的关键酶的活性来阻止病毒，这种酶是病毒复制所需的，并且据信不会在奥密克戎病毒中发生突变。</blockquote></p><p> That is different from Covid-19 vaccines and some treatments that target a different part of the virus, the spike protein, that is the site of many Omicron mutations.</p><p><blockquote>这不同于Covid-19疫苗和一些针对病毒不同部分（刺突蛋白）的治疗方法，刺突蛋白是许多奥密克戎突变的位点。</blockquote></p><p> The early Pfizer laboratory tests showed that Paxlovid blocked the protease enzyme in Omicron, as well as other variants of concern, Dr. Dolsten said.</p><p><blockquote>Dolsten博士说，辉瑞实验室的早期测试表明，Paxlovid阻断了奥密克戎病以及其他令人担忧的变异体中的蛋白酶。</blockquote></p><p> “Without the protease functioning, the virus can’t replicate and cause disease,” Dr. Dolsten said. “I’m very convinced that the effects on Omicron by Paxlovid will be very substantial.”</p><p><blockquote>“如果蛋白酶不发挥作用，病毒就无法复制并导致疾病，”多尔斯滕博士说。“我非常相信Paxlovid对奥密克戎病的影响将是非常大的。”</blockquote></p><p> Pfizer said it plans on performing more testing to measure Paxlovid’s effectiveness against the variant.</p><p><blockquote>辉瑞表示，计划进行更多测试来衡量Paxlovid对该变种的有效性。</blockquote></p><p> In November, Pfizer said an early look at a key study found Paxlovid was 89% effective at reducing the risk of hospitalization and death in high-risk adults.</p><p><blockquote>11月，辉瑞表示，对一项关键研究的早期观察发现，Paxlovid在降低高危成人住院和死亡风险方面的有效性为89%。</blockquote></p><p> The FDA has been waiting for the final results before making an authorization decision, Pfizer Chief Executive Albert Bourla said last week at The Wall Street Journal’s CEO Council.</p><p><blockquote>辉瑞首席执行官Albert Bourla上周在《华尔街日报》首席执行官委员会上表示，FDA一直在等待最终结果，然后再做出授权决定。</blockquote></p><p> In the final analysis, five of the 697 high-risk subjects who received the drug within three days of symptoms were hospitalized or died from Covid-19, compared with 44 out of 682 subjects who received a placebo, Pfizer said.</p><p><blockquote>辉瑞表示，最终分析中，在出现症状三天内接受该药物治疗的697名高危受试者中有5人住院或死于Covid-19，而接受安慰剂治疗的682名受试者中有44人住院或死于Covid-19。</blockquote></p><p> Nine study volunteers who received a placebo died, compared with none in the treatment arm, the company said.</p><p><blockquote>该公司表示，接受安慰剂的研究志愿者中有9人死亡，而治疗组中没有一人死亡。</blockquote></p><p> Researchers also reported the drug was 88% effective if taken within five days of symptoms.</p><p><blockquote>研究人员还报告说，如果在症状出现后五天内服用，该药物的有效率为88%。</blockquote></p><p> The final study analysis of another oral antiviral, from Merck &amp; Co. and partner Ridgeback Biotherapeutics LP, showed a 30% risk reduction, lower than the 50% found during an early look.</p><p><blockquote>默克公司和合作伙伴Ridgeback Biotherapeutics LP对另一种口服抗病毒药物的最终研究分析显示，风险降低了30%，低于早期研究中发现的50%。</blockquote></p><p> Separately, Pfizer has been testing Paxlovid’s effectiveness in people at low risk of developing severe disease, including some who were vaccinated.</p><p><blockquote>另外，辉瑞一直在测试Paxlovid在患严重疾病风险低的人群中的有效性，包括一些接种过疫苗的人。</blockquote></p><p></p><p> The company’s preliminary look at the results found Paxlovid failed to resolve or consistently reduce self-reported symptoms within four days, which was the study’s main goal and a way of determining whether an antiviral is effective.</p><p><blockquote>该公司对结果的初步研究发现，Paxlovid未能在四天内解决或持续减轻自我报告的症状，这是该研究的主要目标，也是确定抗病毒药物是否有效的一种方法。</blockquote></p><p> Two of the 333 low-risk subjects who got Paxlovid were hospitalized, however, compared with eight of 329 subjects who received a placebo, resulting in the 70% efficacy, Pfizer said.</p><p><blockquote>然而，辉瑞表示，接受Paxlovid的333名低风险受试者中有2名住院，而接受安慰剂的329名受试者中有8名住院，有效率为70%。</blockquote></p><p> No subjects had died from Covid-19 in the analysis, which looked at how about 45% of the total number of subjects targeted for the study fared.</p><p><blockquote>在分析中，没有受试者死于Covid-19，该分析考察了该研究目标受试者总数中约45%的受试者的表现。</blockquote></p><p> Dr. Dolsten said Pfizer planned to discuss with health authorities in the U.S. and other countries about potentially making the drug available to low-risk people, and whether Pfizer should do more testing.</p><p><blockquote>多尔斯滕博士表示，辉瑞计划与美国和其他国家的卫生当局讨论向低风险人群提供该药物的可能性，以及辉瑞是否应该进行更多测试。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-says-its-covid-19-pill-likely-works-against-omicron-11639482302?mod=hp_lead_pos1\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.wsj.com/articles/pfizer-says-its-covid-19-pill-likely-works-against-omicron-11639482302?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111446051","content_text":"Preliminary laboratory tests gave encouraging signs that Pfizer Inc.’s PFE 0.62% experimental Covid-19 pill for the newly infected could work against Omicron, the company said.\n\nPfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective at reducing the risk of hospitalization and death in adults at high risk of severe Covid-19.\n\nThe positive results come as the Food and Drug Administration reviews whether to clear use of Paxlovid in high-risk adults, a decision that could come before the end of the year.\n\n“This was a real home run, gives tremendous hope for another highly effective intervention,” Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.\n\nMeanwhile, a separate, preliminary analysis provided signs the drug may help people at low risk of severe Covid-19, such as vaccinated individuals who end up becoming sick.\n\nPaxlovid in the early study analysis reduced the risk of hospitalization and death by 70% in adults at low risk of severe Covid-19, though it failed to reduce or resolve their symptoms within four days.\n\nStudy subjects who were at high risk of developing severe disease had to have at least one characteristic or underlying health condition such as being obese or elderly. The other study included people who were either unvaccinated and at low risk of developing severe disease, such as young and healthy individuals, or vaccinated people with at least one risk factor for developing severe disease.\n\nBoth studies testing Paxlovid in people showed that the amount of virus, or viral load, in subjects who received the drug was significantly less than in the placebo groups, Pfizer said.\n\nA lower viral load could mean less transmission of the virus.\n\nCiting the findings, some analysts said Paxlovid was likely to become the Covid-19 drug of choice for newly infected adults seeking to avoid severe disease. JP Morgan Chase & Co. analysts estimated $18 billion in sales next year.\n\nPfizer shares rose 0.62% in Tuesday trading.\n\nDoctors and health experts have been looking for an antiviral like Paxlovid, which people could easily take at home within several days of symptoms emerging to prevent their cases from turning serious and requiring hospitalization.\n\nThe emergence of Omicron has shadowed the approach of such antivirals, however, because of uncertainty whether the new strain could elude treatments and vaccines.\n\nTo make an assessment, drugmakers have been studying whether authorized and experimental Covid-19 drugs and vaccines are effective against Omicron.\n\nDoctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ\nResearchers suspected Pfizer’s pill would hold up well because it stops the virus by blocking the activity of a key enzyme, known as protease, that the virus needs to replicate and isn’t believed to be mutated in Omicron.\n\n\nThat is different from Covid-19 vaccines and some treatments that target a different part of the virus, the spike protein, that is the site of many Omicron mutations.\n\nThe early Pfizer laboratory tests showed that Paxlovid blocked the protease enzyme in Omicron, as well as other variants of concern, Dr. Dolsten said.\n\n“Without the protease functioning, the virus can’t replicate and cause disease,” Dr. Dolsten said. “I’m very convinced that the effects on Omicron by Paxlovid will be very substantial.”\n\nPfizer said it plans on performing more testing to measure Paxlovid’s effectiveness against the variant.\n\nIn November, Pfizer said an early look at a key study found Paxlovid was 89% effective at reducing the risk of hospitalization and death in high-risk adults.\n\nThe FDA has been waiting for the final results before making an authorization decision, Pfizer Chief Executive Albert Bourla said last week at The Wall Street Journal’s CEO Council.\n\nIn the final analysis, five of the 697 high-risk subjects who received the drug within three days of symptoms were hospitalized or died from Covid-19, compared with 44 out of 682 subjects who received a placebo, Pfizer said.\n\nNine study volunteers who received a placebo died, compared with none in the treatment arm, the company said.\n\nResearchers also reported the drug was 88% effective if taken within five days of symptoms.\n\nThe final study analysis of another oral antiviral, from Merck & Co. and partner Ridgeback Biotherapeutics LP, showed a 30% risk reduction, lower than the 50% found during an early look.\n\nSeparately, Pfizer has been testing Paxlovid’s effectiveness in people at low risk of developing severe disease, including some who were vaccinated.\n\nThe company’s preliminary look at the results found Paxlovid failed to resolve or consistently reduce self-reported symptoms within four days, which was the study’s main goal and a way of determining whether an antiviral is effective.\n\nTwo of the 333 low-risk subjects who got Paxlovid were hospitalized, however, compared with eight of 329 subjects who received a placebo, resulting in the 70% efficacy, Pfizer said.\n\n\nNo subjects had died from Covid-19 in the analysis, which looked at how about 45% of the total number of subjects targeted for the study fared.\n\nDr. Dolsten said Pfizer planned to discuss with health authorities in the U.S. and other countries about potentially making the drug available to low-risk people, and whether Pfizer should do more testing.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604761061,"gmtCreate":1639447123313,"gmtModify":1639447123313,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604761061","repostId":"2191984334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604785779,"gmtCreate":1639446757391,"gmtModify":1639446757391,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"23andMeAirBnBLegalZoom","listText":"23andMeAirBnBLegalZoom","text":"23andMeAirBnBLegalZoom","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604785779","repostId":"2191988412","repostType":4,"isVote":1,"tweetType":1,"viewCount":1971,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604702709,"gmtCreate":1639443598303,"gmtModify":1639443598362,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Unity with their Unreal Engine 5 is promising I think","listText":"Unity with their Unreal Engine 5 is promising I think","text":"Unity with their Unreal Engine 5 is promising I think","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604702709","repostId":"1183432073","repostType":4,"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605742181,"gmtCreate":1639272265796,"gmtModify":1639272265896,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Fella is eccentric&nbsp;","listText":"Fella is eccentric&nbsp;","text":"Fella is eccentric","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605742181","repostId":"2190620320","repostType":4,"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605746186,"gmtCreate":1639272211046,"gmtModify":1639272211148,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582014945835134","authorIdStr":"3582014945835134"},"themes":[],"htmlText":"Can they compete with AMD's chiplet technology?&nbsp;","listText":"Can they compete with AMD's chiplet technology?&nbsp;","text":"Can they compete with AMD's chiplet technology?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605746186","repostId":"2190671014","repostType":4,"isVote":1,"tweetType":1,"viewCount":619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690410169,"gmtCreate":1639700487566,"gmtModify":1639700487661,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Soon Apple will not be reliant on Intel and Qualcomm anymore&nbsp;","listText":"Soon Apple will not be reliant on Intel and Qualcomm anymore&nbsp;","text":"Soon Apple will not be reliant on Intel and Qualcomm anymore","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690410169","repostId":"2192941918","repostType":4,"isVote":1,"tweetType":1,"viewCount":1157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604761061,"gmtCreate":1639447123313,"gmtModify":1639447123313,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604761061","repostId":"2191984334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698310150,"gmtCreate":1640303506313,"gmtModify":1640303506584,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Christmas hype","listText":"Christmas hype","text":"Christmas hype","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698310150","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":2430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607773751,"gmtCreate":1639610087948,"gmtModify":1639610088044,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Amazing how the market turned green with the news and expectations of this","listText":"Amazing how the market turned green with the news and expectations of this","text":"Amazing how the market turned green with the news and expectations of this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607773751","repostId":"1172651405","repostType":4,"repost":{"id":"1172651405","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639595340,"share":"https://www.laohu8.com/m/news/1172651405?lang=zh_CN&edition=full","pubTime":"2021-12-16 03:09","market":"us","language":"en","title":"Dow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172651405","media":"Tiger Newspress","summary":"U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve he","content":"<p>U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. </p><p><blockquote>周三下午，美国股市基准小幅走高，美联储一如预期维持利率稳定，但加快了缩减债券购买计划的步伐，为2022年上半年加息打开了大门。</blockquote></p><p> Projections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. </p><p><blockquote>美联储预计明年将加息三次，目前联邦基金利率在0%至0.25%之间。美联储主席杰罗姆·鲍威尔将于美国东部时间下午2:30召开新闻发布会，讨论央行的最新政策。</blockquote></p><p> The move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. </p><p><blockquote>比官员们上个月会议上计划的更早结束刺激计划的举动提供了最具体的迹象，表明鲍威尔的重点已转向防止通胀上升变得根深蒂固。</blockquote></p><p> But the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. </p><p><blockquote>但更新后的政策出台之际，冠状病毒的奥密克戎变种导致了COVID-19的传播，引发了人们对经济复苏和供应链瓶颈的新担忧，这些瓶颈有助于支撑通胀上升。</blockquote></p><p> The Dow Jones Industrial Average&nbsp;popped into positive territory, up 0.3% at 35,645, the S&amp;P 500 index&nbsp;climbed 0.3% to 4,650, and the Nasdaq Composite Index&nbsp;briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note&nbsp;yields 1.46% from around 1.44% before the Fed update.</p><p><blockquote>道琼斯工业平均指数上涨0.3%，至35,645点，标普500指数上涨0.3%，至4,650点，纳斯达克综合指数短暂上涨不到0.1%，至15,269点。10年期国债收益率从美联储更新前的1.44%左右升至1.46%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow industrials pop up and stock market tries to clamber higher, even as Fed projections point to 3 rate hikes in 2022<blockquote>尽管美联储预测2022年将加息3次，道琼斯工业指数飙升，股市试图攀升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 03:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. </p><p><blockquote>周三下午，美国股市基准小幅走高，美联储一如预期维持利率稳定，但加快了缩减债券购买计划的步伐，为2022年上半年加息打开了大门。</blockquote></p><p> Projections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. </p><p><blockquote>美联储预计明年将加息三次，目前联邦基金利率在0%至0.25%之间。美联储主席杰罗姆·鲍威尔将于美国东部时间下午2:30召开新闻发布会，讨论央行的最新政策。</blockquote></p><p> The move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. </p><p><blockquote>比官员们上个月会议上计划的更早结束刺激计划的举动提供了最具体的迹象，表明鲍威尔的重点已转向防止通胀上升变得根深蒂固。</blockquote></p><p> But the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. </p><p><blockquote>但更新后的政策出台之际，冠状病毒的奥密克戎变种导致了COVID-19的传播，引发了人们对经济复苏和供应链瓶颈的新担忧，这些瓶颈有助于支撑通胀上升。</blockquote></p><p> The Dow Jones Industrial Average&nbsp;popped into positive territory, up 0.3% at 35,645, the S&amp;P 500 index&nbsp;climbed 0.3% to 4,650, and the Nasdaq Composite Index&nbsp;briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note&nbsp;yields 1.46% from around 1.44% before the Fed update.</p><p><blockquote>道琼斯工业平均指数上涨0.3%，至35,645点，标普500指数上涨0.3%，至4,650点，纳斯达克综合指数短暂上涨不到0.1%，至15,269点。10年期国债收益率从美联储更新前的1.44%左右升至1.46%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172651405","content_text":"U.S. stock benchmarks on Wednesday afternoon were pivoting modestly higher as the Federal Reserve held interest rates steady, as expected, but quickened the pace of wind-down of its bond-buying program, opening the door to interest-rate increases in the first half of 2022. \nProjections from the Fed point to three rate increases next year, with the current fed-funds rate at a range between 0% and 0.25%. Fed Chairman Jerome Powell will host a news conference at 2:30 p.m. ET to discuss the central bank's updated policy. \nThe move to end the stimulus program sooner than officials planned at their meeting last month offers the most concrete sign of how Powell's focus has shifted toward preventing higher inflation from becoming entrenched. \nBut the updated policy comes as the omicron variant of the coronavirus that causes COVID-19 spreads, sparking fresh concerns about economic recovery and supply-chain bottlenecks that have helped underpin rising inflation. \nThe Dow Jones Industrial Average popped into positive territory, up 0.3% at 35,645, the S&P 500 index climbed 0.3% to 4,650, and the Nasdaq Composite Index briefly climbed to less than 0.1% higher at 15,269. The 10-year Treasury note yields 1.46% from around 1.44% before the Fed update.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607812179,"gmtCreate":1639524492603,"gmtModify":1639524492603,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607812179","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605282906,"gmtCreate":1639181419825,"gmtModify":1639181419885,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Continue to drop pls haha","listText":"Continue to drop pls haha","text":"Continue to drop pls haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605282906","repostId":"1133027099","repostType":4,"repost":{"id":"1133027099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639152670,"share":"https://www.laohu8.com/m/news/1133027099?lang=zh_CN&edition=full","pubTime":"2021-12-11 00:11","market":"us","language":"en","title":"Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133027099","media":"Tiger Newspress","summary":"Sea Ltd stock dropped more than 5% in morning trading.","content":"<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-11 00:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133027099","content_text":"Sea Ltd stock dropped more than 5% in morning trading.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602857871,"gmtCreate":1639009329981,"gmtModify":1639009330516,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Booster again..","listText":"Booster again..","text":"Booster again..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/602857871","repostId":"1141815911","repostType":4,"repost":{"id":"1141815911","kind":"news","pubTimestamp":1639007843,"share":"https://www.laohu8.com/m/news/1141815911?lang=zh_CN&edition=full","pubTime":"2021-12-09 07:57","market":"us","language":"en","title":"Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞称加强剂中和了奥密克戎病毒，但变种可能无法注射两剂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141815911","media":"The Wall Street Journal","summary":"Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine ","content":"<p>Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.</p><p><blockquote>辉瑞公司PFE-0.62%和BioNTech SE BNTX-3.55%表示，他们的第三剂Covid-19疫苗在实验室测试中中和了奥密克戎变种，但两剂方案在阻断病毒方面的效果明显较差。</blockquote></p><p> A third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.</p><p><blockquote>两家公司表示，与针对奥密克戎变种的两剂相比，第三剂使抗体增加了25倍。他们说，尽管如此，两剂疫苗可能会有效预防Covid-19引起的严重疾病，因为免疫细胞能够识别疫苗靶向的刺突蛋白的80%部分。</blockquote></p><p> The results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.</p><p><blockquote>这些结果是在两家公司的新闻稿中发布的，没有经过同行评审也没有发表在科学期刊上。</blockquote></p><p> The findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.</p><p><blockquote>两家公司的早期研究结果以及南非科学家的一项研究结果表明，需要三剂疫苗才能产生与早期病毒株仅两剂疫苗类似的针对奥密克戎病毒的免疫反应。</blockquote></p><p> It also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.</p><p><blockquote>两家公司表示，这也支持了重复和定期加强剂以维持人们对不断发展的Covid-19的免疫防御的理由。</blockquote></p><p> “This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.</p><p><blockquote>辉瑞首席科学官米凯尔·多尔斯滕(Mikael Dolsten)表示，“这是一个非常积极的消息，应该会让每个人都更有动力接种疫苗”并接种加强剂。</blockquote></p><p> The companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.</p><p><blockquote>多尔斯滕博士说，两家公司目前的疫苗将为奥密克戎提供强有力的防御，特别是如果人们接受加强注射的话。他补充说，三剂方案可以在整个冬季提供针对奥密克戎病毒的权宜之计，直到需要时直接针对该变种的新疫苗准备就绪。</blockquote></p><p> Pfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.</p><p><blockquote>辉瑞和BioNTech正在研究一种针对奥密克戎病毒的疫苗，如果该变种到那时变得广泛传播，他们希望在2022年3月之前上市。奥密克戎病毒被发现后不久，研究人员于11月25日感恩节开始研究这种新疫苗。</blockquote></p><p> The vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.</p><p><blockquote>该疫苗通过产生称为抗体的免疫系统士兵来训练免疫系统对抗病毒，抗体附着在病毒上并阻止其在健康细胞中复制。该疫苗还产生其他称为T细胞的免疫系统战士，可以在感染后发挥作用，帮助靶向和清除病毒，预防更严重的疾病。</blockquote></p><p> Pfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.</p><p><blockquote>辉瑞和BioNTech表示，奥密克戎似乎仍然容易受到疫苗产生的T细胞的影响。</blockquote></p><p> Dr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.</p><p><blockquote>多尔斯滕博士估计，到春季，奥密克戎病毒成为美国传播的主要毒株的可能性超过50%，但现在确定还为时过早。</blockquote></p><p> The preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.</p><p><blockquote>初步实验室数据来自对接种疫苗患者血液样本的分析，测量能够中和导致Covid-19的病毒（包括奥密克戎变种）的抗体。在患者接受第二剂后三周或接受第三剂后一个月采集血样。</blockquote></p><p> The number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.</p><p><blockquote>两家公司表示，针对奥密克戎病毒的第三次加强注射产生的抗体数量与针对旧病毒株的两次注射相似。</blockquote></p><p> “These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.</p><p><blockquote>“这些初步数据似乎表明辉瑞疫苗确实可以预防奥密克戎病毒，这是一个非常好的消息，”Boston College全球公共卫生和全球公益项目主任Philip Landrigan说。</blockquote></p><p> Monica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.</p><p><blockquote>加州大学旧金山分校医学教授莫妮卡·甘地表示，结果表明，两剂疫苗将保护许多人免于出现导致住院或死亡的严重病例。</blockquote></p><p> “Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”</p><p><blockquote>甘地博士说：“无论人们是否接种加强剂，两剂疫苗对严重疾病仍然有效。”他建议为包括艾滋病毒感染者在内的高危患者接种加强剂。“对于患有严重疾病的高风险人群来说，给他们注射疫苗非常重要，但我认为这对于年轻的健康人来说并不是强制性的。”</blockquote></p><p> The company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.</p><p><blockquote>该公司的早期发现发布前一天，南非科学家报告了早期实验室测试的结果，表明辉瑞-BioNTech疫苗对奥密克戎病毒的中和作用比原始版本的病毒降低了41倍。</blockquote></p><p> The researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.</p><p><blockquote>然而，研究人员发现，从完全接种疫苗且之前感染过Covid-19的受试者身上采集的血液中，针对奥密克戎病毒的抗体反应更强。</blockquote></p><p> The companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.</p><p><blockquote>BioNTech首席执行官Uğur Ş ahin表示，尽管有令人鼓舞的迹象表明，使用原始疫苗加强注射可以很好地预防奥密克戎病，但两家公司仍将继续研究变异疫苗。这是因为他们需要看到更多关于他们的疫苗如何抵抗新变种的数据，包括预计在未来几周内的真实世界有效性数据。</blockquote></p><p> “Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.</p><p><blockquote>他说：“只有结合起来，我们才能了解这些数据的相关性以及对奥密克戎病介导的疾病和严重疾病的潜在保护作用。”</blockquote></p><p> Real-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.</p><p><blockquote>Ş ahin博士说，有关奥密克戎疫苗有效性的真实数据至少在六周内无法获得，因为病例数需要更高才能衡量。</blockquote></p><p></p><p> Meanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.</p><p><blockquote>与此同时，两家公司正在推进奥密克戎专用疫苗的生产。BioNTech高管表示，用于实验用途的第一剂疫苗将于1月份准备就绪。</blockquote></p><p> Omicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.</p><p><blockquote>上个月，科学家首次在南非发现了奥密克戎病毒。从那时起，世界卫生组织就认为这是一个值得关注的变种。此后，包括美国在内的世界各地都发现了这种病毒。</blockquote></p><p> Researchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.</p><p><blockquote>研究人员一直在试图了解这种新毒株的传染性如何，以及它逃避Covid-19疫苗的能力如何，以及它是否会导致严重疾病。一些初步报告表明，这种变异更具传染性，但可能会导致较轻的疾病，尽管研究人员表示现在知道还为时过早。</blockquote></p><p> Pfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.</p><p><blockquote>辉瑞和BioNTech表示，他们预计明年将生产40亿剂疫苗，即使届时需要奥密克戎专用疫苗。</blockquote></p><p> Dr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.</p><p><blockquote>多尔斯滕博士说，无论奥密克戎病变得多么普遍，未来可能需要持续的加强注射来提供针对新冠肺炎的保护。他说，2022年春季或秋季可能需要第四次加强剂量。</blockquote></p><p> “It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”</p><p><blockquote>多尔斯滕博士说：“越来越明显的是，你需要有长远的眼光，持续增强才能拥有强大持久的免疫力。”“如果情况看起来与今天相似，我们可能会继续使用当前的疫苗加强疫苗。”</blockquote></p><p> Pfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.</p><p><blockquote>辉瑞股价上涨1%，而BioNTech美国存托股早盘下跌0.2%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞称加强剂中和了奥密克戎病毒，但变种可能无法注射两剂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞称加强剂中和了奥密克戎病毒，但变种可能无法注射两剂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-12-09 07:57</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.</p><p><blockquote>辉瑞公司PFE-0.62%和BioNTech SE BNTX-3.55%表示，他们的第三剂Covid-19疫苗在实验室测试中中和了奥密克戎变种，但两剂方案在阻断病毒方面的效果明显较差。</blockquote></p><p> A third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.</p><p><blockquote>两家公司表示，与针对奥密克戎变种的两剂相比，第三剂使抗体增加了25倍。他们说，尽管如此，两剂疫苗可能会有效预防Covid-19引起的严重疾病，因为免疫细胞能够识别疫苗靶向的刺突蛋白的80%部分。</blockquote></p><p> The results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.</p><p><blockquote>这些结果是在两家公司的新闻稿中发布的，没有经过同行评审也没有发表在科学期刊上。</blockquote></p><p> The findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.</p><p><blockquote>两家公司的早期研究结果以及南非科学家的一项研究结果表明，需要三剂疫苗才能产生与早期病毒株仅两剂疫苗类似的针对奥密克戎病毒的免疫反应。</blockquote></p><p> It also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.</p><p><blockquote>两家公司表示，这也支持了重复和定期加强剂以维持人们对不断发展的Covid-19的免疫防御的理由。</blockquote></p><p> “This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.</p><p><blockquote>辉瑞首席科学官米凯尔·多尔斯滕(Mikael Dolsten)表示，“这是一个非常积极的消息，应该会让每个人都更有动力接种疫苗”并接种加强剂。</blockquote></p><p> The companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.</p><p><blockquote>多尔斯滕博士说，两家公司目前的疫苗将为奥密克戎提供强有力的防御，特别是如果人们接受加强注射的话。他补充说，三剂方案可以在整个冬季提供针对奥密克戎病毒的权宜之计，直到需要时直接针对该变种的新疫苗准备就绪。</blockquote></p><p> Pfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.</p><p><blockquote>辉瑞和BioNTech正在研究一种针对奥密克戎病毒的疫苗，如果该变种到那时变得广泛传播，他们希望在2022年3月之前上市。奥密克戎病毒被发现后不久，研究人员于11月25日感恩节开始研究这种新疫苗。</blockquote></p><p> The vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.</p><p><blockquote>该疫苗通过产生称为抗体的免疫系统士兵来训练免疫系统对抗病毒，抗体附着在病毒上并阻止其在健康细胞中复制。该疫苗还产生其他称为T细胞的免疫系统战士，可以在感染后发挥作用，帮助靶向和清除病毒，预防更严重的疾病。</blockquote></p><p> Pfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.</p><p><blockquote>辉瑞和BioNTech表示，奥密克戎似乎仍然容易受到疫苗产生的T细胞的影响。</blockquote></p><p> Dr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.</p><p><blockquote>多尔斯滕博士估计，到春季，奥密克戎病毒成为美国传播的主要毒株的可能性超过50%，但现在确定还为时过早。</blockquote></p><p> The preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.</p><p><blockquote>初步实验室数据来自对接种疫苗患者血液样本的分析，测量能够中和导致Covid-19的病毒（包括奥密克戎变种）的抗体。在患者接受第二剂后三周或接受第三剂后一个月采集血样。</blockquote></p><p> The number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.</p><p><blockquote>两家公司表示，针对奥密克戎病毒的第三次加强注射产生的抗体数量与针对旧病毒株的两次注射相似。</blockquote></p><p> “These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.</p><p><blockquote>“这些初步数据似乎表明辉瑞疫苗确实可以预防奥密克戎病毒，这是一个非常好的消息，”Boston College全球公共卫生和全球公益项目主任Philip Landrigan说。</blockquote></p><p> Monica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.</p><p><blockquote>加州大学旧金山分校医学教授莫妮卡·甘地表示，结果表明，两剂疫苗将保护许多人免于出现导致住院或死亡的严重病例。</blockquote></p><p> “Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”</p><p><blockquote>甘地博士说：“无论人们是否接种加强剂，两剂疫苗对严重疾病仍然有效。”他建议为包括艾滋病毒感染者在内的高危患者接种加强剂。“对于患有严重疾病的高风险人群来说，给他们注射疫苗非常重要，但我认为这对于年轻的健康人来说并不是强制性的。”</blockquote></p><p> The company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.</p><p><blockquote>该公司的早期发现发布前一天，南非科学家报告了早期实验室测试的结果，表明辉瑞-BioNTech疫苗对奥密克戎病毒的中和作用比原始版本的病毒降低了41倍。</blockquote></p><p> The researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.</p><p><blockquote>然而，研究人员发现，从完全接种疫苗且之前感染过Covid-19的受试者身上采集的血液中，针对奥密克戎病毒的抗体反应更强。</blockquote></p><p> The companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.</p><p><blockquote>BioNTech首席执行官Uğur Ş ahin表示，尽管有令人鼓舞的迹象表明，使用原始疫苗加强注射可以很好地预防奥密克戎病，但两家公司仍将继续研究变异疫苗。这是因为他们需要看到更多关于他们的疫苗如何抵抗新变种的数据，包括预计在未来几周内的真实世界有效性数据。</blockquote></p><p> “Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.</p><p><blockquote>他说：“只有结合起来，我们才能了解这些数据的相关性以及对奥密克戎病介导的疾病和严重疾病的潜在保护作用。”</blockquote></p><p> Real-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.</p><p><blockquote>Ş ahin博士说，有关奥密克戎疫苗有效性的真实数据至少在六周内无法获得，因为病例数需要更高才能衡量。</blockquote></p><p></p><p> Meanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.</p><p><blockquote>与此同时，两家公司正在推进奥密克戎专用疫苗的生产。BioNTech高管表示，用于实验用途的第一剂疫苗将于1月份准备就绪。</blockquote></p><p> Omicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.</p><p><blockquote>上个月，科学家首次在南非发现了奥密克戎病毒。从那时起，世界卫生组织就认为这是一个值得关注的变种。此后，包括美国在内的世界各地都发现了这种病毒。</blockquote></p><p> Researchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.</p><p><blockquote>研究人员一直在试图了解这种新毒株的传染性如何，以及它逃避Covid-19疫苗的能力如何，以及它是否会导致严重疾病。一些初步报告表明，这种变异更具传染性，但可能会导致较轻的疾病，尽管研究人员表示现在知道还为时过早。</blockquote></p><p> Pfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.</p><p><blockquote>辉瑞和BioNTech表示，他们预计明年将生产40亿剂疫苗，即使届时需要奥密克戎专用疫苗。</blockquote></p><p> Dr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.</p><p><blockquote>多尔斯滕博士说，无论奥密克戎病变得多么普遍，未来可能需要持续的加强注射来提供针对新冠肺炎的保护。他说，2022年春季或秋季可能需要第四次加强剂量。</blockquote></p><p> “It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”</p><p><blockquote>多尔斯滕博士说：“越来越明显的是，你需要有长远的眼光，持续增强才能拥有强大持久的免疫力。”“如果情况看起来与今天相似，我们可能会继续使用当前的疫苗加强疫苗。”</blockquote></p><p> Pfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.</p><p><blockquote>辉瑞股价上涨1%，而BioNTech美国存托股早盘下跌0.2%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-biontech-covid-19-vaccine-loses-significant-effectiveness-against-omicron-in-early-study-companies-say-11638964121?mod=hp_lead_pos1\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.wsj.com/articles/pfizer-biontech-covid-19-vaccine-loses-significant-effectiveness-against-omicron-in-early-study-companies-say-11638964121?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141815911","content_text":"Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.\n\nA third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.\n\nThe results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.\n\nThe findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.\n\n\nIt also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.\n\n“This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.\n\nThe companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.\n\nPfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.\n\nThe vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.\n\nPfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.\n\nDr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.\n\nThe preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.\n\nThe number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.\n\n“These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.\n\n\nMonica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.\n\n“Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”\n\nThe company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.\n\n\n\nThe researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.\n\nThe companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.\n\n\n“Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.\n\nReal-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.\n\nMeanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.\n\nOmicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.\n\nResearchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.\n\nPfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.\n\nDr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.\n\n“It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”\n\nPfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693438162,"gmtCreate":1640058771445,"gmtModify":1640059673375,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"No way home","listText":"No way home","text":"No way home","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693438162","repostId":"1148092447","repostType":4,"repost":{"id":"1148092447","kind":"news","pubTimestamp":1640057971,"share":"https://www.laohu8.com/m/news/1148092447?lang=zh_CN&edition=full","pubTime":"2021-12-21 11:39","market":"us","language":"en","title":"Disney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148092447","media":"Investopedia","summary":"Box-office success of latest installment suggests merchandise sales opportunity","content":"<p><b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>The latest installment in the Spiderman franchise is setting box-office records.</li>  <li>Disney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.</li>  <li>Typically, merchandise sales for Spiderman movies track box-office performance.</li> </ul> In a bit of welcome news for the beleaguered entertainment industry,<i>Spider-Man: No Way Home</i>, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind&nbsp;<i>Avengers: Endgame</i>&nbsp;and&nbsp;<i>Avengers: Infinity War</i>.</p><p><blockquote><ul><li>蜘蛛侠系列的最新一部正在创造票房记录。</li><li>迪士尼不会从索尼制作的蜘蛛侠电影的票房收入中获利，但会从商品销售中获利。</li><li>通常，蜘蛛侠电影的商品销售会跟踪票房表现。</li></ul>对于陷入困境的娱乐业来说，这是个好消息。<i>蜘蛛侠：英雄无归</i>漫威电影宇宙（MCU）的最新电影，上周末票房大卖。据报道，这部电影在国内获得了2.53亿美元的票房，是2021年首映的最高票房。它还从海外市场获得了3.342亿美元的票房，总票房为5.872亿美元，成为有史以来第三好的首映票房，仅次于<i>复仇者联盟：终局之战</i>和<i>复仇者联盟3：无限战争</i>.</blockquote></p><p> But The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.</p><p><blockquote>但拥有MCU的华特迪士尼公司（DIS）可能不会从最新蜘蛛侠电影的票房收入中赚到一分钱。相反，该公司从漫威合资企业中获得的利润来源将来自商品销售。</blockquote></p><p> <b>A Spidey Partnership</b></p><p><blockquote><b>蜘蛛侠伙伴关系</b></blockquote></p><p> Even though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company&nbsp;purchased the rights&nbsp;to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.</p><p><blockquote>尽管蜘蛛侠是迪士尼旗下MCU的一部分，但以彼得·帕克为主角的电影是由索尼集团公司（Sony）制作的。这家总部位于东京的公司早在1999年就购买了web slinger的版权，当时漫威还是一个独立的实体。作为购买协议的一部分，漫威从索尼制作和发行的电影中获得总票房的5%，而两家公司则平分商品收入。</blockquote></p><p> The terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.</p><p><blockquote>这种合作关系的条款在2011年发生了变化。漫威已经在2009年被迪士尼收购。2011年急需现金的索尼修改了协议，放弃了其商品销售份额，而迪士尼则放弃了其票房收入份额。</blockquote></p><p> Typically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of&nbsp;<i>Spiderman 3</i>&nbsp;in 2007. But they fell to $200 million after the unsuccessful debut of&nbsp;<i>The Amazing Spiderman 2</i>&nbsp;in 2014.2</p><p><blockquote>通常，蜘蛛侠系列的商品销售会跟踪票房收入。蜘蛛侠电影越成功，其商品销量就越大。例如，在大片上映后，商品销售额总计3.97亿美元。<i>蜘蛛侠3</i>2007年。但在首次亮相不成功后，他们的收入跌至2亿美元<i>超凡蜘蛛侠2</i>于2014.2</blockquote></p><p> Even during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.</p><p><blockquote>即使在销售低迷的时候，就商品销售而言，蜘蛛侠也是一个摇钱树。到2014年，与该动作玩偶相关的全球零售额估计为每年13亿美元，使蜘蛛侠成为最成功的系列。</blockquote></p><p> The equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.</p><p><blockquote>商品销售和票房表现之间的等式预示着迪士尼从最新一期《蜘蛛侠》中获得的利润。它的元宇宙主题跨越了不同的时间线和角色，也为来自过去和现在的特许经营不同阶段的角色提供了许多许可机会。根据License Global杂志的数据，House of Mouse是2018年全球最大的授权商，全球授权商品零售额为547亿美元。</blockquote></p><p></p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney Could See Big Profits From Spiderman Merchandise<blockquote>迪士尼可以从蜘蛛侠商品中获得巨额利润</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investopedia</strong><span class=\"h-time small\">2021-12-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>The latest installment in the Spiderman franchise is setting box-office records.</li>  <li>Disney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.</li>  <li>Typically, merchandise sales for Spiderman movies track box-office performance.</li> </ul> In a bit of welcome news for the beleaguered entertainment industry,<i>Spider-Man: No Way Home</i>, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind&nbsp;<i>Avengers: Endgame</i>&nbsp;and&nbsp;<i>Avengers: Infinity War</i>.</p><p><blockquote><ul><li>蜘蛛侠系列的最新一部正在创造票房记录。</li><li>迪士尼不会从索尼制作的蜘蛛侠电影的票房收入中获利，但会从商品销售中获利。</li><li>通常，蜘蛛侠电影的商品销售会跟踪票房表现。</li></ul>对于陷入困境的娱乐业来说，这是个好消息。<i>蜘蛛侠：英雄无归</i>漫威电影宇宙（MCU）的最新电影，上周末票房大卖。据报道，这部电影在国内获得了2.53亿美元的票房，是2021年首映的最高票房。它还从海外市场获得了3.342亿美元的票房，总票房为5.872亿美元，成为有史以来第三好的首映票房，仅次于<i>复仇者联盟：终局之战</i>和<i>复仇者联盟3：无限战争</i>.</blockquote></p><p> But The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.</p><p><blockquote>但拥有MCU的华特迪士尼公司（DIS）可能不会从最新蜘蛛侠电影的票房收入中赚到一分钱。相反，该公司从漫威合资企业中获得的利润来源将来自商品销售。</blockquote></p><p> <b>A Spidey Partnership</b></p><p><blockquote><b>蜘蛛侠伙伴关系</b></blockquote></p><p> Even though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company&nbsp;purchased the rights&nbsp;to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.</p><p><blockquote>尽管蜘蛛侠是迪士尼旗下MCU的一部分，但以彼得·帕克为主角的电影是由索尼集团公司（Sony）制作的。这家总部位于东京的公司早在1999年就购买了web slinger的版权，当时漫威还是一个独立的实体。作为购买协议的一部分，漫威从索尼制作和发行的电影中获得总票房的5%，而两家公司则平分商品收入。</blockquote></p><p> The terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.</p><p><blockquote>这种合作关系的条款在2011年发生了变化。漫威已经在2009年被迪士尼收购。2011年急需现金的索尼修改了协议，放弃了其商品销售份额，而迪士尼则放弃了其票房收入份额。</blockquote></p><p> Typically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of&nbsp;<i>Spiderman 3</i>&nbsp;in 2007. But they fell to $200 million after the unsuccessful debut of&nbsp;<i>The Amazing Spiderman 2</i>&nbsp;in 2014.2</p><p><blockquote>通常，蜘蛛侠系列的商品销售会跟踪票房收入。蜘蛛侠电影越成功，其商品销量就越大。例如，在大片上映后，商品销售额总计3.97亿美元。<i>蜘蛛侠3</i>2007年。但在首次亮相不成功后，他们的收入跌至2亿美元<i>超凡蜘蛛侠2</i>于2014.2</blockquote></p><p> Even during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.</p><p><blockquote>即使在销售低迷的时候，就商品销售而言，蜘蛛侠也是一个摇钱树。到2014年，与该动作玩偶相关的全球零售额估计为每年13亿美元，使蜘蛛侠成为最成功的系列。</blockquote></p><p> The equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.</p><p><blockquote>商品销售和票房表现之间的等式预示着迪士尼从最新一期《蜘蛛侠》中获得的利润。它的元宇宙主题跨越了不同的时间线和角色，也为来自过去和现在的特许经营不同阶段的角色提供了许多许可机会。根据License Global杂志的数据，House of Mouse是2018年全球最大的授权商，全球授权商品零售额为547亿美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investopedia.com/disney-could-profit-from-spiderman-merchandise-5213902\">Investopedia</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"https://www.investopedia.com/disney-could-profit-from-spiderman-merchandise-5213902","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148092447","content_text":"KEY TAKEAWAYS\n\nThe latest installment in the Spiderman franchise is setting box-office records.\nDisney does not profit from the from box-office receipts of Sony-produced Spiderman films but stands to gain from merchandise sales.\nTypically, merchandise sales for Spiderman movies track box-office performance.\n\nIn a bit of welcome news for the beleaguered entertainment industry,Spider-Man: No Way Home, the latest movie from the Marvel Cinematic Universe (MCU), tore up the box-office this past weekend. According to reports, the movie collected $253 million at the domestic box office for the the highest debut of 2021. It also collected $334.2 million from overseas markets for total takings of $587.2 million, making it the third-best opening of all time behind Avengers: Endgame and Avengers: Infinity War.\nBut The Walt Disney Company (DIS), which owns MCU, will probably not make a single penny from the latest Spiderman movie's box-office receipts. Instead, the company's source of profits from this Marvel venture will come from merchandise sales.\nA Spidey Partnership\nEven though Spiderman is part of the Disney-owned MCU, movies featuring Peter Parker are produced by Sony Group Corp. (SONY). The Tokyo-based company purchased the rights to the web slinger back in 1999, when Marvel was an independent entity. As part of the purchase agreement, Marvel received 5% of the overall ticket sales from movies produced and distributed by Sony, while the two companies split merchandising revenue.\nThe terms of that partnership changed in 2011. Marvel had already been purchased by Disney in 2009. Sony, which was in dire need of cash in 2011, reworked the agreement and let go of its share of merchandising sales, while Disney forwent its share of box-office receipts.\nTypically, merchandise sales for the Spiderman franchise have tracked box-office receipts. The more successful a Spiderman movie, the greater the sales of its merchandise. For example, merchandise sales totaled $397 million after the blockbuster release of Spiderman 3 in 2007. But they fell to $200 million after the unsuccessful debut of The Amazing Spiderman 2 in 2014.2\nEven during times of flagging sales, Spiderman has been a money-spinner as far as merchandising is concerned. Global retail sales related to the action figure were estimated to be $1.3 billion annually by 2014, making Spiderman the most successful franchise.\nThe equation between merch sales and box office performance bodes well for Disney's profits from the latest installment of Spiderman. Its metaverse theme, which spans different timelines and characters, also provides many opportunities for licensing characters from different stages of the franchise, past and present. The House of Mouse was the world's top licensor in 2018, with $54.7 billion in retail sales of licensed merchandise worldwide, according to License Global magazine.","news_type":1,"symbols_score_info":{"DIS":0.9}},"isVote":1,"tweetType":1,"viewCount":2432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699418865,"gmtCreate":1639875630158,"gmtModify":1639875630277,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Let's go up up up","listText":"Let's go up up up","text":"Let's go up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699418865","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=zh_CN&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week<blockquote>华尔街在经历了大部分负面的一周后收盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-18 07:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p><p><blockquote>（路透社）-华尔街周五收低，受大型科技股拖累，投资者担心奥密克戎冠状病毒变种，并更快消化美联储结束大流行时期刺激措施的决定。</blockquote></p><p> All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p><p><blockquote>在美联储周三暗示在2022年底前加息三次0.25个百分点以应对飙升的通胀后，美国三大主要股指本周均收跌。</blockquote></p><p> Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p><p><blockquote>英伟达下跌2.1%，Alphabet下跌1.9%，均令标普500和纳斯达克承压。</blockquote></p><p> The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p><p><blockquote>标普500增长指数下跌0.7%，价值指数下跌1.4%。</blockquote></p><p> All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p><p><blockquote>标普500 11大板块指数悉数下跌，金融股跌幅2.3%领跌。能源下跌2.2%。</blockquote></p><p> Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p><p><blockquote>辉瑞周五表示，疫情可能会延续到明年，这增加了不确定性。欧洲国家为进一步的旅行和社会限制做好了准备，一项研究警告说，迅速传播的奥密克戎冠状病毒变种重新感染人类的可能性是其前身达美航空的五倍。</blockquote></p><p> Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p><p><blockquote>交易员还指出，年终税收抛售以及股票期权、股指期货和指数期权合约同时到期——被称为三重巫术——是波动的潜在原因。</blockquote></p><p> \"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p><p><blockquote>新泽西州查塔姆Themis Trading交易联席经理Joe Saluzzi表示：“这是一个重要的期权到期日。”“现在你在此基础上利用一些奥密克戎，就会出现波动，我认为这给投资者带来了很多不确定性。今年年底你打算在哪里定位？”</blockquote></p><p> Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p><p><blockquote>包括英伟达和微软在内的权重成长股在2021年的表现优于大盘，而费城SE半导体指数则飙升了约35%。基准标普500指数同期上涨约23%。</blockquote></p><p> In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p><p><blockquote>周五交易中，道琼斯工业平均指数下跌1.48%，收于35,365.44点，标普500下跌1.03%，收于4,620.64点。</blockquote></p><p> The Nasdaq Composite dropped 0.07% to 15,169.68.</p><p><blockquote>纳斯达克综合指数下跌0.07%，至15,169.68点。</blockquote></p><p> On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p><p><blockquote>积极的一面是，小盘股罗素2000指数在从11月初的历史高点下跌超过10%后，上涨了1%。</blockquote></p><p> With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p><p><blockquote>随着期权到期，美国交易所的成交量跃升至166亿股，远高于过去20个交易日119亿股的平均水平。</blockquote></p><p> For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p><p><blockquote>本周，标普500下跌1.9%，道琼斯指数下跌1.7%，纳斯达克下跌2.9%。</blockquote></p><p> In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p><p><blockquote>周五交易中，甲骨文股价下跌6.4%，此前《华尔街日报》报道称，这家企业软件制造商正在就收购电子医疗记录公司Cerner进行谈判，交易价值可能达到300亿美元。Cerner股价飙升12.9%。</blockquote></p><p> FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p><p><blockquote>尽管持续的劳工困境削弱了利润，但联邦快递公司周四恢复了最初的2022财年预测，该公司股价上涨近5%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.50比1；在纳斯达克，1.16比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p><p><blockquote>标普500创下22个52周新高和7个新低；纳斯达克综合指数录得28个新高和341个新低。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":2308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605742181,"gmtCreate":1639272265796,"gmtModify":1639272265896,"author":{"id":"3582014945835134","authorId":"3582014945835134","name":"MrTurtle","avatar":"https://static.tigerbbs.com/e7ea443f0a60070e2ee5d8fc5d161a4f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582014945835134","idStr":"3582014945835134"},"themes":[],"htmlText":"Fella is eccentric&nbsp;","listText":"Fella is eccentric&nbsp;","text":"Fella is eccentric","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605742181","repostId":"2190620320","repostType":4,"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}